<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.mdpi.com/journal/pharmaceutics');</script>

        <script> var body_html = '<body> <div > <div > <div > <a > <h2>25th Anniversary</h2> </a> <a > <h2>Journals</h2> </a> <div > <div > <h2>Information</h2> </div> <div > <div > <div > <a >For Authors</a> <a >For Reviewers</a> <a >For Editors</a> <a >For Librarians</a> <a >For Publishers</a> <a >For Societies</a> </div> <div > <a >Article Processing Charges</a> <a >Open Access Policy</a> <a >Institutional Open Access Program</a> <a >Editorial Process</a> <a >Awards</a> <a >Research and Publication Ethics</a> </div> </div> </div> </div> <a > <h2>Author Services</h2> </a> <div > <div > <h2>Initiatives</h2> </div> <div > <div > <div > <a >Sciforum</a> <a >MDPI Books</a> <a >Preprints</a> <a >Scilit</a> <a >SciProfiles</a> <a >Encyclopedia</a> <a >JAMS</a> <a >Proceedings Series</a> </div> </div> </div> </div> <a > <h2>About</h2> </a> </div> <div > <a >Sign In / Sign Up</a> </div> </div> </div> <div > <h2 >Notice</h2> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div > <div > <a >Continue</a> <a >Cancel</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div > <p> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div > <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div > <div >  </div> <section > <header> <div > <div > <div > <ul> <li > <a >25th Anniversary</a> </li> <li > <a >Journals</a> </li> <li > <a >Information</a> <ul > <li> <div > <div > <ul> <li> <a >For Authors</a> </li> <li> <a >For Reviewers</a> </li> <li> <a >For Editors</a> </li> <li> <a >For Librarians</a> </li> <li> <a >For Publishers</a> </li> <li> <a >For Societies</a> </li> </ul> </div> <div > <ul> <li> <a >Article Processing Charges</a> </li> <li> <a >Open Access Policy</a> </li> <li> <a >Institutional Open Access Program</a> </li> <li> <a >Editorial Process</a> </li> <li> <a >Awards</a> </li> <li> <a >Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >Author Services</a> </li> <li > <a >Initiatives</a> <ul > <li> <div > <div > <ul> <li> <a > Sciforum </a> </li> <li> <a > MDPI Books </a> </li> <li> <a > Preprints </a> </li> <li> <a > Scilit </a> </li> <li> <a > SciProfiles </a> </li> <li> <a > Encyclopedia </a> </li> <li> <a > JAMS </a> </li> <li> <a > Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li > <a >About</a> </li> </ul> </div> <div > <div> <a >Sign In / Sign Up</a> <a >Submit</a> </div> </div> </div> </div> <div > <div > <div > <div > <a > Covered in: PubMed </a> </div></div> <div > <div > <a > IMPACTFACTOR 6.321 </a> </div> </div> </div> <div > Journals </div> <div > Pharmaceutics </div> </div> </header> <div > <div > <div > <div > <div > <h2 >Journal Description</h2> </div> <div > <div > <h1> Pharmaceutics </h1> <div > Pharmaceutics is a <a >peer-reviewed</a>, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published monthly online by MDPI. <a >The Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG)</a>, <a >Pharmaceutical Solid State Research Cluster (PSSRC)</a>, <a >Academy of Pharmaceutical Sciences (APS)</a> and <a >Korean Society of Pharmaceutical Sciences and Technology (KSPST)</a> are affiliated with Pharmaceutics and their members receive a discount on the article processing charges. <ul> <li>Open Access— free for readers, with <a >article processing charges (APC)</a> paid by authors or their institutions.</li> <li>High Visibility: indexed within <a >Scopus</a>, <a >SCIE (Web of Science)</a>, <a >PubMed</a>, <a >PMC</a>, <a >Embase</a>, <a >CAPlus / SciFinder</a>, and many <a >other databases</a>.</li> <li>Journal Rank: JCR - Q1 (Pharmacology Pharmacy) / CiteScore - Q2 (Pharmaceutical Science)</li> <li>Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.5 days after submission; acceptance to publication is undertaken in 3.7 days (median values for papers published in this journal in the first half of 2021).</li> <li>Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li>Companion journal: Future Pharmacology</li> </ul> </div> <div > Impact Factor: 6.321 (2020) ; 5-Year Impact Factor: 6.734 (2020) </div> <div> <a > <i >subject</i> Imprint Information </a> <a > <i >get_app</i> Journal Flyer </a> <a > Open Access </a> ISSN: 1999-4923 </div> </div> </div> </div> <div > <div > <h2 >Latest Articles</h2> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: <a >Abstract Page</a> <a >Full-Text HTML</a> </div> </div> <div >Open AccessArticle</div> Use of Microfluidic Capillary Electrophoresis for the Determination of Multi-Component Protein Adsorption Isotherms: Application to High-Throughput Analysis for Hydrophobic Interaction Chromatography <div > by <span ><div >Elena Lietta</div>, </span><span ><div >Alessandro Pieri</div>, </span><span ><div >Elisa Innocenti</div>, </span><span ><div >Roberto Pisano</div>, </span><span ><div >Marco Vanni</div> and </span><span ><div >Antonello A. Barresi</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2135; https://doi.org/10.3390/pharmaceutics13122135 (registering DOI) - 11 Dec 2021 </div> <div > Abstract <div > Chromatography is a widely used separation process for purification of biopharmaceuticals that is able to obtain high purities and concentrations. The phenomena that occur during separation, mass transfer and adsorption are quite complex. To better understand these phenomena and their mechanisms, multi-component adsorption [...] Read more. </div> <div > Chromatography is a widely used separation process for purification of biopharmaceuticals that is able to obtain high purities and concentrations. The phenomena that occur during separation, mass transfer and adsorption are quite complex. To better understand these phenomena and their mechanisms, multi-component adsorption isotherms must be investigated. High-throughput methodologies are a very powerful tool to determine adsorption isotherms and they waste very small amounts of sample and chemicals, but the quantification of component concentrations is a real bottleneck in multi-component isotherm determination. The behavior of bovine serum albumin, <i>Corynebacterium diphtheriae</i> CRM<sub>197</sub> protein and lysozyme, selected as model proteins in binary mixtures with hydrophobic resin, is investigated here. In this work we propose a new method for determining multi-component adsorption isotherms using high-throughput experiments with filter plates, by exploiting microfluidic capillary electrophoresis. The precision and accuracy of the microfluidic capillary electrophoresis platform were evaluated in order to assess the procedure; they were both found to be high and the procedure is thus reliable in determining adsorption isotherms for binary mixtures. Multi-component adsorption isotherms were determined with a totally high-throughput procedure that turned out to be a very fast and powerful tool. The same procedure can be applied to every kind of high-throughput screening. Full article </div> </div> <div > (This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessArticle</div> Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines <div > by <span ><div >Aytug Kara</div>, </span><span ><div >Athina Vassiliadou</div>, </span><span ><div >Baris Ongoren</div>, </span><span ><div >William Keeble</div>, </span><span ><div >Richard Hing</div>, </span><span ><div >Aikaterini Lalatsa</div> and </span><span ><div >Dolores R. Serrano</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2134; https://doi.org/10.3390/pharmaceutics13122134 (registering DOI) - 10 Dec 2021 </div> <div > Abstract <div > Currently, there is an unmet need to manufacture nanomedicines in a continuous and controlled manner. Three-dimensional (3D) printed microfluidic chips are an alternative to conventional PDMS chips as they can be easily designed and manufactured to allow for customized designs that are able [...] Read more. </div> <div > Currently, there is an unmet need to manufacture nanomedicines in a continuous and controlled manner. Three-dimensional (3D) printed microfluidic chips are an alternative to conventional PDMS chips as they can be easily designed and manufactured to allow for customized designs that are able to reproducibly manufacture nanomedicines at an affordable cost. The manufacturing of microfluidic chips using existing 3D printing technologies remains very challenging because of the intricate geometry of the channels. Here, we demonstrate the manufacture and characterization of nifedipine (NFD) polymeric nanoparticles based on Eudragit L-100 using 3D printed microfluidic chips with 1 mm diameter channels produced with two 3D printing techniques that are widely available, stereolithography (SLA) and fuse deposition modeling (FDM). Fabricated polymeric nanoparticles showed good encapsulation efficiencies and particle sizes in the range of 50–100 nm. SLA chips possessed better channel resolution and smoother channel surfaces, leading to smaller particle sizes similar to those obtained by conventional manufacturing methods based on solvent evaporation, while SLA manufactured nanoparticles showed a minimal burst effect in acid media compared to nanoparticles fabricated with FDM chips. Three-dimensional printed microfluidic chips are a novel and easily amenable cost-effective strategy to allow for customization of the design process for continuous manufacture of nanomedicines under controlled conditions, enabling easy scale-up and reducing nanomedicine development times, while maintaining high-quality standards. Full article </div> </div> <div > (This article belongs to the Special Issue Advances in Microfluidics for Pharmaceutical Applications) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 488 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Assessment and Modeling of Plasmonic Photothermal Therapy Delivered via a Fiberoptic Microneedle Device Ex Vivo <div > by <span ><div >Forhad Akhter</div>, </span><span ><div >Santiago Manrique-Bedoya</div>, </span><span ><div >Chris Moreau</div>, </span><span ><div >Andrea Lynn Smith</div>, </span><span ><div >Yusheng Feng</div>, </span><span ><div >Kathryn M. Mayer</div> and </span><span ><div >R. Lyle Hood</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2133; https://doi.org/10.3390/pharmaceutics13122133 - 10 Dec 2021 </div> <div > Abstract <div > Plasmonic photothermal therapy (PPTT) has potential as a superior treatment method for pancreatic cancer, a disease with high mortality partially attributable to the currently non-selective treatment options. PPTT utilizes gold nanoparticles infused into a targeted tissue volume and exposed to a specific light [...] Read more. </div> <div > Plasmonic photothermal therapy (PPTT) has potential as a superior treatment method for pancreatic cancer, a disease with high mortality partially attributable to the currently non-selective treatment options. PPTT utilizes gold nanoparticles infused into a targeted tissue volume and exposed to a specific light wavelength to induce selective hyperthermia. The current study focuses on developing this approach within an ex vivo porcine pancreas model via an innovative fiberoptic microneedle device (FMD) for co-delivering light and gold nanoparticles. The effects of laser wavelengths (808 vs. 1064 nm), irradiances (20–50 mW·mm<sup>−2</sup>), and gold nanorod (GNR) concentrations (0.1–3 nM) on tissue temperature profiles were evaluated to assess and control hyperthermic generation. The GNRs had a peak absorbance at ~800 nm. Results showed that, at 808 nm, photon absorption and subsequent heat generation within tissue without GNRs was 65% less than 1064 nm. The combination of GNRs and 808 nm resulted in a 200% higher temperature rise than the 1064 nm under similar conditions. A computational model was developed to predict the temperature shift and was validated against experimental results with a deviation of &lt;5%. These results show promise for both a predictive model and spatially selective, tunable treatment modality for pancreatic cancer. Full article </div> </div> <div > (This article belongs to the Special Issue Advances in Microneedle-Based Drug Delivery Systems Volume II) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 558 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice <div > by <span ><div >Nouran R. R. Zaid</div>, </span><span ><div >Peter Kletting</div>, </span><span ><div >Gordon Winter</div>, </span><span ><div >Vikas Prasad</div>, </span><span ><div >Ambros J. Beer</div> and </span><span ><div >Gerhard Glatting</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2132; https://doi.org/10.3390/pharmaceutics13122132 - 10 Dec 2021 </div> <div > Abstract <div > In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (α-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to address concerns about the [...] Read more. </div> <div > In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (α-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to address concerns about the efficacy and safety of α-PRRT. A murine whole-body physiologically based pharmacokinetic (PBPK) model was developed for <sup>212</sup>Pb-labeled somatostatin analogs (<sup>212</sup>Pb-SSTA). The model describes pharmacokinetics of <sup>212</sup>Pb-SSTA and its decay products, including specific and non-specific glomerular and tubular uptake. Absorbed dose coefficients (ADC) were calculated for bound and unbound radiolabeled SSTA and its decay products. Kidneys received the highest ADC (134 Gy/MBq) among non-target tissues. The alpha-emitting <sup>212</sup>Po contributes more than 50% to absorbed doses in most tissues. Using this model, it is demonstrated that α-PRRT based on <sup>212</sup>Pb-SSTA results in lower absorbed doses in non-target tissue than α-PRRT based on <sup>212</sup>Bi-SSTA for a given kidneys absorbed dose. In both approaches, the energies released in the glomeruli and proximal tubules account for 54% and 46%, respectively, of the total energy absorbed in kidneys. The <sup>212</sup>Pb-SSTA-PBPK model accelerates the translation from bench to bedside by enabling better experimental design and by improving the understanding of the underlying mechanisms. Full article </div> </div> <div > (This article belongs to the Special Issue Physiologically-Based Pharmacokinetics (PBPK) and Biopharmaceutics (PBBM) Modeling) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability <div > by <span ><div >Daniel Andrés Real</div>, </span><span ><div >Karen Bolaños</div>, </span><span ><div >Josefina Priotti</div>, </span><span ><div >Nicolás Yutronic</div>, </span><span ><div >Marcelo J. Kogan</div>, </span><span ><div >Rodrigo Sierpe</div> and </span><span ><div >Orlando Donoso-González</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2131; https://doi.org/10.3390/pharmaceutics13122131 - 10 Dec 2021 </div> <div > Abstract <div > In drug delivery, one widely used way of overcoming the biopharmaceutical problems present in several active pharmaceutical ingredients, such as poor aqueous solubility, early instability, and low bioavailability, is the formation of inclusion compounds with cyclodextrins (CD). In recent years, the use of [...] Read more. </div> <div > In drug delivery, one widely used way of overcoming the biopharmaceutical problems present in several active pharmaceutical ingredients, such as poor aqueous solubility, early instability, and low bioavailability, is the formation of inclusion compounds with cyclodextrins (CD). In recent years, the use of CD derivatives in combination with nanomaterials has shown to be a promising strategy for formulating new, optimized systems. The goals of this review are to give in-depth knowledge and critical appraisal of the main CD-modified or CD-based nanomaterials for drug delivery, such as lipid-based nanocarriers, natural and synthetic polymeric nanocarriers, nanosponges, graphene derivatives, mesoporous silica nanoparticles, plasmonic and magnetic nanoparticles, quantum dots and other miscellaneous systems such as nanovalves, metal-organic frameworks, Janus nanoparticles, and nanofibers. Special attention is given to nanosystems that achieve controlled drug release and increase their bioavailability during in vivo studies. Full article </div> </div> <div > (This article belongs to the Special Issue Cyclodextrins in Drug Delivery) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Low Blue Dose Photodynamic Therapy with Porphyrin-Iron Oxide Nanoparticles Complexes: In Vitro Study on Human Melanoma Cells <div > by <span ><div >Simona Nistorescu</div>, </span><span ><div >Ana-Maria Udrea</div>, </span><span ><div >Madalina Andreea Badea</div>, </span><span ><div >Iulia Lungu</div>, </span><span ><div >Mihai Boni</div>, </span><span ><div >Tatiana Tozar</div>, </span><span ><div >Florian Dumitrache</div>, </span><span ><div >Valentin-Adrian Maraloiu</div>, </span><span ><div >Roua Gabriela Popescu</div>, </span><span ><div >Claudiu Fleaca</div>, </span><span ><div >Ecaterina Andronescu</div>, </span><span ><div >Anca Dinischiotu</div>, </span><span ><div >Angela Staicu</div> and </span><span ><div >Mihaela Balas</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2130; https://doi.org/10.3390/pharmaceutics13122130 - 10 Dec 2021 </div> <div > Abstract <div > The purpose of this study was to investigate the effectiveness in photodynamic therapy of iron oxide nanoparticles (γ-Fe<sub>2</sub>O<sub>3</sub> NPs), synthesized by laser pyrolysis technique, functionalized with 5,10,15,20-(Tetra-4-sulfonatophenyl) porphyrin tetraammonium (TPPS) on human cutaneous melanoma cells, after only 1 min blue [...] Read more. </div> <div > The purpose of this study was to investigate the effectiveness in photodynamic therapy of iron oxide nanoparticles (γ-Fe<sub>2</sub>O<sub>3</sub> NPs), synthesized by laser pyrolysis technique, functionalized with 5,10,15,20-(Tetra-4-sulfonatophenyl) porphyrin tetraammonium (TPPS) on human cutaneous melanoma cells, after only 1 min blue light exposure. The efficiency of porphyrin loading on the iron oxide nanocarriers was estimated by using absorption and FTIR spectroscopy. The singlet oxygen yield was determined via transient characteristics of singlet oxygen phosphorescence at 1270 nm both for porphyrin functionalized nanoparticles and rose bengal used as standard. The irradiation was performed with a LED (405 nm, 1 mW/cm<sup>2</sup>) for 1 min after melanoma cells were treated with TPPS functionalized iron oxide nanoparticles (γ-Fe<sub>2</sub>O<sub>3</sub> NPs_TPPS) and incubated for 24 h. Biological tests revealed a high anticancer effect of γ-Fe<sub>2</sub>O<sub>3</sub> NPs_TPPS complexes indi-cated by the inhibition of tumor cell proliferation, reduction of cell adhesion, and induction of cell death through ROS generated by TPPS under light exposure. The biological assays were combined with the pharmacokinetic prediction of the porphyrin. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Anticancer Strategies (Volume II)) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions <div > by <span ><div >Elka Touitou</div> and </span><span ><div >Hiba Natsheh</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2129; https://doi.org/10.3390/pharmaceutics13122129 - 10 Dec 2021 </div> <div > Abstract <div > This review focuses on the improved topical treatment of various medical skin conditions by the use of drugs delivered from carriers containing phospholipid soft vesicles. Topical drug delivery has many advantages over other ways of administration, having increased patient compliance, avoiding the first-pass [...] Read more. </div> <div > This review focuses on the improved topical treatment of various medical skin conditions by the use of drugs delivered from carriers containing phospholipid soft vesicles. Topical drug delivery has many advantages over other ways of administration, having increased patient compliance, avoiding the first-pass effect following oral drug administration or not requesting multiple doses administration. However, the skin barrier prevents the access of the applied drug, affecting its therapeutic activity. Carriers containing phospholipid soft vesicles are a new approach to enhance drug delivery into the skin and to improve the treatment outcome. These vesicles contain molecules that have the property to fluidize the phospholipid bilayers generating the soft vesicle and allowing it to penetrate into the deep skin layers. Ethosomes, glycerosomes and transethosomes are soft vesicles containing ethanol, glycerol or a mixture of ethanol and a surfactant, respectively. We review a large number of publications on the research carried out in vitro, in vivo in animal models and in humans in clinical studies, with compositions containing various active molecules for treatment of skin medical conditions including skin infections, skin inflammation, psoriasis, skin cancer, acne vulgaris, hair loss, psoriasis and skin aging. Full article </div> </div> <div > (This article belongs to the Special Issue Women in Pharmaceutics) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 831 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing—A Translational Example for Intensive Care Units <div > by <span ><div >Ferdinand Anton Weinelt</div>, </span><span ><div >Miriam Songa Stegemann</div>, </span><span ><div >Anja Theloe</div>, </span><span ><div >Frieder Pfäfflin</div>, </span><span ><div >Stephan Achterberg</div>, </span><span ><div >Lisa Schmitt</div>, </span><span ><div >Wilhelm Huisinga</div>, </span><span ><div >Robin Michelet</div>, </span><span ><div >Stefanie Hennig</div> and </span><span ><div >Charlotte Kloft</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2128; https://doi.org/10.3390/pharmaceutics13122128 - 10 Dec 2021 </div> <div > Abstract <div > The prevalence and mortality rates of severe infections are high in intensive care units (ICUs). At the same time, the high pharmacokinetic variability observed in ICU patients increases the risk of inadequate antibiotic drug exposure. Therefore, dosing tailored to specific patient characteristics has [...] Read more. </div> <div > The prevalence and mortality rates of severe infections are high in intensive care units (ICUs). At the same time, the high pharmacokinetic variability observed in ICU patients increases the risk of inadequate antibiotic drug exposure. Therefore, dosing tailored to specific patient characteristics has a high potential to improve outcomes in this vulnerable patient population. This study aimed to develop a tabular dosing decision tool for initial therapy of meropenem integrating hospital-specific, thus far unexploited pathogen susceptibility information. An appropriate meropenem pharmacokinetic model was selected from the literature and evaluated using clinical data. Probability of target attainment (PTA) analysis was conducted for clinically interesting dosing regimens. To inform dosing prior to pathogen identification, the local pathogen-independent mean fraction of response (LPIFR) was calculated based on the observed minimum inhibitory concentrations distribution in the hospital. A simple, tabular, model-informed dosing decision tool was developed for initial meropenem therapy. Dosing recommendations achieving PTA &gt; 90% or LPIFR &gt; 90% for patients with different creatinine clearances were integrated. Based on the experiences during the development process, a generalised workflow for the development of tabular dosing decision tools was derived. The proposed workflow can support the development of model-informed dosing tools for initial therapy of various drugs and hospital-specific conditions. Full article </div> </div> <div > (This article belongs to the Special Issue Model-Informed Precision Dosing) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page </div> </div> <div >Open AccessReview</div> Polymeric Materials for Hemostatic Wound Healing <div > by <span ><div >Suvash Ghimire</div>, </span><span ><div >Pritha Sarkar</div>, </span><span ><div >Kasey Rigby</div>, </span><span ><div >Aditya Maan</div>, </span><span ><div >Santanu Mukherjee</div>, </span><span ><div >Kaitlyn E. Crawford</div> and </span><span ><div >Kausik Mukhopadhyay</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2127; https://doi.org/10.3390/pharmaceutics13122127 - 09 Dec 2021 </div> <div > Abstract <div > Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal [...] Read more. </div> <div > Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal or internal hemorrhages are more challenging to treat with regular hemostatic dressings because of deep wounds and points of injury that cannot be located properly. The need to treat trauma wounds from limbs, abdomen, liver, stomach, colon, spleen, arterial, venous, and/or parenchymal hemorrhage accompanied by severe bleeding requires an immediate solution that the first responders can apply to reduce rapid exsanguinations from external wounds, including in military operations. This necessitates the development of a unique, easy-to-use, FDA-approved hemostatic treatment that can deliver the agent in less than 30 s and stop bleeding within the first 1 to 2 min at the point of injury without application of manual pressure on the wounded area. Full article </div> </div> <div > (This article belongs to the Special Issue Advances in Wound Dressings and Materials) </div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Spin Freezing and Its Impact on Pore Size, Tortuosity and Solid State <div > by <span ><div >Joris Lammens</div>, </span><span ><div >Niloofar Moazami Goudarzi</div>, </span><span ><div >Laurens Leys</div>, </span><span ><div >Gust Nuytten</div>, </span><span ><div >Pieter-Jan Van Bockstal</div>, </span><span ><div >Chris Vervaet</div>, </span><span ><div >Matthieu N. Boone</div> and </span><span ><div >Thomas De Beer</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2126; https://doi.org/10.3390/pharmaceutics13122126 - 09 Dec 2021 </div> <div > Abstract <div > Spin freeze-drying, as a part of a continuous freeze-drying technology, is associated with a much higher drying rate and a higher level of process control in comparison with batch freeze-drying. However, the impact of the spin freezing rate on the dried product layer [...] Read more. </div> <div > Spin freeze-drying, as a part of a continuous freeze-drying technology, is associated with a much higher drying rate and a higher level of process control in comparison with batch freeze-drying. However, the impact of the spin freezing rate on the dried product layer characteristics is not well understood at present. This research focuses on the relation between spin-freezing and pore size, pore shape, dried product mass transfer resistance and solid state of the dried product layer. This was thoroughly investigated via high-resolution X-ray micro-computed tomography (µCT), scanning electron microscopy (SEM), thermal imaging and solid state X-ray diffraction (XRD). It was concluded that slow spin-freezing rates resulted in the formation of highly tortuous structures with a high dried-product mass-transfer resistance, while fast spin-freezing rates resulted in lamellar structures with a low tortuosity and low dried-product mass-transfer resistance. Full article </div> </div> <div > (This article belongs to the Special Issue New Trends in Freeze-Drying of Pharmaceutical Products) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 1150 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Submerged Eutectic-Assisted, Solvent-Free Mechanochemical Formation of a Propranolol Salt and Its Other Multicomponent Solids <div > by <span ><div >Klaudia Bialek</div>, </span><span ><div >Zaneta Wojnarowska</div>, </span><span ><div >Marcin Skotnicki</div>, </span><span ><div >Brendan Twamley</div>, </span><span ><div >Marian Paluch</div> and </span><span ><div >Lidia Tajber</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2125; https://doi.org/10.3390/pharmaceutics13122125 - 09 Dec 2021 </div> <div > Abstract <div > Salt preparation via a solid-state reaction offers a solution to challenges posed by current pharmaceutical research, which include combining development of novel forms of active pharmaceutical ingredients with greener, sustainable synthesis. This work investigated in detail the mechanism of salt formation between propranolol [...] Read more. </div> <div > Salt preparation via a solid-state reaction offers a solution to challenges posed by current pharmaceutical research, which include combining development of novel forms of active pharmaceutical ingredients with greener, sustainable synthesis. This work investigated in detail the mechanism of salt formation between propranolol (PRO) and capric acid (CAP) and explored the solid eutectic phases comprising this salt, propranolol caprate (PRC). The salt structure was solved by X-ray diffraction, and the properties in the crystalline and supercooled states were fully characterised using thermal analysis, nuclear magnetic resonance, Fourier-transform infrared spectroscopy and broadband dielectric spectroscopy (BDS). PRC forms via a submerged eutectic phase composed of PRO and CAP, below room temperature, by mechanochemistry without an extra input of energy. Two other solid eutectic phases are composed of PRC and either CAP or PRO, at 0.28 and 0.82 mol fraction of PRO, respectively. BDS indicated that the supercooled PRC has ionic character, whereas the supercooled PRC-PRO eutectic had predominantly non-ionic properties despite comprising the salt. In conclusion, knowledge of the mechanism of formation of multicomponent systems can help in designing more sustainable pharmaceutical processes. Full article </div> </div> <div > (This article belongs to the Section Physical Pharmacy and Formulation) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 223 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Incorporation of Zinc into Binary SiO<sub>2</sub>-CaO Mesoporous Bioactive Glass Nanoparticles Enhances Anti-Inflammatory and Osteogenic Activities</a> <div > by <span ><div >Haishui Sun</div>, </span><span ><div >Kai Zheng</div>, </span><span ><div >Tian Zhou</div> and </span><span ><div >Aldo R. Boccaccini</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2124; https://doi.org/10.3390/pharmaceutics13122124 - 09 Dec 2021 </div> <div > Abstract <div > During the healing and repair of bone defects, uncontrolled inflammatory responses can compromise bone regeneration. Biomaterials with anti-inflammatory activity are favorable for bone tissue regeneration processes. In this work, multifunctional Zn-containing mesoporous bioactive glass nanoparticles (Zn-MBGs) exhibiting favorable osteogenic and anti-inflammatory activities were [...] Read more. </div> <div > During the healing and repair of bone defects, uncontrolled inflammatory responses can compromise bone regeneration. Biomaterials with anti-inflammatory activity are favorable for bone tissue regeneration processes. In this work, multifunctional Zn-containing mesoporous bioactive glass nanoparticles (Zn-MBGs) exhibiting favorable osteogenic and anti-inflammatory activities were produced employing a sol-gel method. Zn-MBGs exhibited a mesoporous spherical shape and nanoscale particle size (100 ± 20 nm). They were degradable in cell culture medium, and could release Si, Ca, and Zn in a sustained manner. Zn-MBGs also exhibited a concentration-dependent cellular response. The extract of Zn-MBGs obtained by incubation at 0.1 mg/mL (in culture medium) for 24 h could enhance in vitro mineralization, alkaline phosphatase activity, the expression of osteogenesis-related genes, and the production of intracellular protein osteocalcin of rat bone marrow stromal cells (BMSCs). Moreover, the extract of Zn-MBGs at 0.1 mg/mL could significantly downregulate the expression of inflammatory genes and the production of inducible nitric oxide in RAW 264.7 cells, particularly under stimulation of inflammatory signals interferon-γ (IFN-γ) and lipopolysaccharide (LPS). Zn-MBGs also inhibited the pro-inflammatory M1 polarization of RAW264.7 cells induced by LPS and IFN-γ. In summary, we successfully synthesized Zn-MBGs with concentration-dependent osteogenic and anti-inflammatory activities. Zn-MBGs show their great potential in immunomodulation strategies for bone regeneration, representing a multifunctional biomaterial that can be applied to regenerate bone defects under inflammatory conditions. Full article </div> </div> <div > (This article belongs to the Special Issue Commemorative Issue in Honor of Professor Maria Vallet Regí: 20 Years of Silica-Based Mesoporous Materials) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 546 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> 3D-Printed Coating of Extended-Release Matrix Tablets: Effective Tool for Prevention of Alcohol-Induced Dose Dumping Effect <div > by <span ><div >Barbora Skalická</div>, </span><span ><div >Kevin Matzick</div>, </span><span ><div >Alena Komersová</div>, </span><span ><div >Roman Svoboda</div>, </span><span ><div >Martin Bartoš</div> and </span><span ><div >Luděk Hromádko</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2123; https://doi.org/10.3390/pharmaceutics13122123 - 09 Dec 2021 </div> <div > Abstract <div > Tablets used for extended drug release commonly contain large amounts of drugs. The corresponding drug release mechanism thus has to be well-known and invariable under numerous conditions in order to prevent any uncontrolled drug release. Particularly important is the stability and invariability of [...] Read more. </div> <div > Tablets used for extended drug release commonly contain large amounts of drugs. The corresponding drug release mechanism thus has to be well-known and invariable under numerous conditions in order to prevent any uncontrolled drug release. Particularly important is the stability and invariability of the release mechanism in the presence of alcohol due to the possible occurrence of the dose dumping effect. The effect of 3D printing (3DP) coating on the drug release mechanism and the drug release rate was studied as a possible tool for the prevention of the alcohol-induced dose dumping effect. Three types of matrix tablets (hydrophilic, lipophilic, and hydrophilic-lipophilic) were prepared by the direct compression method and coated using 3DP. The commercial filament of polyvinyl alcohol (PVA) and the filament prepared from hypromellose by hot melt extrusion (HME) were used as coating materials. Both coating materials were characterized by SEM, DSC, Raman spectroscopy, and PXRD during particular stages of the processing/coating procedure. The dissolution behavior of the uncoated and coated tablets was studied in the strongly acidic (pH 1.2) and alcoholic (40% of ethanol) dissolution media. The dissolution tests in the alcoholic medium showed that the Affinisol coating was effective in preventing the dose dumping incidence. The dissolution tests in the acidic dissolution media showed that the Affinisol coating can also be useful for the delayed release of active substances. Full article </div> </div> <div > (This article belongs to the Special Issue Advanced Pharmaceutical Research in the Czech Republic) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 1601 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood–Brain Barrier in Epileptic Patients <div > by <span ><div >Risa Sato</div>, </span><span ><div >Kotaro Ohmori</div>, </span><span ><div >Mina Umetsu</div>, </span><span ><div >Masaki Takao</div>, </span><span ><div >Mitsutoshi Tano</div>, </span><span ><div >Gerald Grant</div>, </span><span ><div >Brenda Porter</div>, </span><span ><div >Anthony Bet</div>, </span><span ><div >Tetsuya Terasaki</div> and </span><span ><div >Yasuo Uchida</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2122; https://doi.org/10.3390/pharmaceutics13122122 - 09 Dec 2021 </div> <div > Abstract <div > The purpose of the present study was to quantitatively elucidate the levels of protein expression of anti-epileptic-drug (AED) transporters, metabolizing enzymes and tight junction molecules at the blood–brain barrier (BBB) in the focal site of epilepsy patients using accurate SWATH (sequential window acquisition [...] Read more. </div> <div > The purpose of the present study was to quantitatively elucidate the levels of protein expression of anti-epileptic-drug (AED) transporters, metabolizing enzymes and tight junction molecules at the blood–brain barrier (BBB) in the focal site of epilepsy patients using accurate SWATH (sequential window acquisition of all theoretical fragment ion spectra) proteomics. Brain capillaries were isolated from focal sites in six epilepsy patients and five normal brains; tryptic digests were produced and subjected to SWATH analysis. MDR1 and BCRP were significantly downregulated in the epilepsy group compared to the normal group. Out of 16 AED-metabolizing enzymes detected, the protein expression levels of GSTP1, GSTO1, CYP2E1, ALDH1A1, ALDH6A1, ALDH7A1, ALDH9A1 and ADH5 were significantly 2.13-, 6.23-, 2.16-, 2.80-, 1.73-, 1.67-, 2.47- and 2.23-fold greater in the brain capillaries of epileptic patients than those of normal brains, respectively. The protein expression levels of Claudin-5, ZO-1, Catenin alpha-1, beta-1 and delta-1 were significantly lower, 1.97-, 2.51-, 2.44-, 1.90- and 1.63-fold, in the brain capillaries of epileptic patients compared to those of normal brains, respectively. Consistent with these observations, leakage of blood proteins was also observed. These results provide for a better understanding of the therapeutic effect of AEDs and molecular mechanisms of AED resistance in epileptic patients. Full article </div> </div> <div > (This article belongs to the Section Clinical Pharmaceutics) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 366 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> <a >Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium <i>Pseudomonas gessardii</i> M15 against Herpes Simplex Viruses and Coronaviruses</a> <div > by <span ><div >Rosa Giugliano</div>, </span><span ><div >Carmine Buonocore</div>, </span><span ><div >Carla Zannella</div>, </span><span ><div >Annalisa Chianese</div>, </span><span ><div >Fortunato Palma Esposito</div>, </span><span ><div >Pietro Tedesco</div>, </span><span ><div >Anna De Filippis</div>, </span><span ><div >Massimiliano Galdiero</div>, </span><span ><div >Gianluigi Franci</div> and </span><span ><div >Donatella de Pascale</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2121; https://doi.org/10.3390/pharmaceutics13122121 - 08 Dec 2021 </div> <div > Abstract <div > Emerging and re-emerging viruses represent a serious threat to human health at a global level. In particular, enveloped viruses are one of the main causes of viral outbreaks, as recently demonstrated by SARS-CoV-2. An effective strategy to counteract these viruses could be to [...] Read more. </div> <div > Emerging and re-emerging viruses represent a serious threat to human health at a global level. In particular, enveloped viruses are one of the main causes of viral outbreaks, as recently demonstrated by SARS-CoV-2. An effective strategy to counteract these viruses could be to target the envelope by using surface-active compounds. Rhamnolipids (RLs) are microbial biosurfactants displaying a wide range of bioactivities, such as antibacterial, antifungal and antibiofilm, among others. Being of microbial origin, they are environmentally-friendly, biodegradable, and less toxic than synthetic surfactants. In this work, we explored the antiviral activity of the rhamnolipids mixture (M15RL) produced by the Antarctic bacteria <i>Pseudomonas gessardii</i> M15 against viruses belonging to <i>Coronaviridae</i> and <i>Herpesviridae</i> families. In addition, we investigated the rhamnolipids’ mode of action and the possibility of inactivating viruses on treated surfaces. Our results show complete inactivation of HSV-1 and HSV-2 by M15RLs at 6 µg/mL, and of HCoV-229E and SARS-CoV-2 at 25 and 50 µg/mL, respectively. Concerning activity against HCoV-OC43, 80% inhibition of cytopathic effect was recorded, while no activity against naked Poliovirus Type 1 (PV-1) was detectable, suggesting that the antiviral action is mainly directed towards the envelope. In conclusion, we report a significant activity of M15RL against enveloped viruses and demonstrated for the first time the antiviral effect of rhamnolipids against SARS-CoV-2. Full article </div> </div> <div > (This article belongs to the Special Issue Biosurfactants as Multifunctional Ingredients for Emerging Pharmaceutical Formulations) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review <div > by <span ><div >Shadab Md</div>, </span><span ><div >Nabil A. Alhakamy</div>, </span><span ><div >Shahid Karim</div>, </span><span ><div >Gamal A Gabr</div>, </span><span ><div >Mohammad Kashif Iqubal</div> and </span><span ><div >Samar S. A. Murshid</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2120; https://doi.org/10.3390/pharmaceutics13122120 - 08 Dec 2021 </div> <div > Abstract <div > Lung cancer is one of the most commonly diagnosed cancers and is responsible for a large number of deaths worldwide. The pathogenic mechanism of lung cancer is complex and multifactorial in origin. Thus, various signaling pathways as targets for therapy are being examined, [...] Read more. </div> <div > Lung cancer is one of the most commonly diagnosed cancers and is responsible for a large number of deaths worldwide. The pathogenic mechanism of lung cancer is complex and multifactorial in origin. Thus, various signaling pathways as targets for therapy are being examined, and many new drugs are in the pipeline. However, both conventional and target-based drugs have been reported to present significant adverse effects, and both types of drugs can affect the clinical outcome in addition to patient quality of life. Recently, miRNA has been identified as a promising target for lung cancer treatment. Therefore, miRNA mimics, oncomiRs, or miRNA suppressors have been developed and studied for possible anticancer effects. However, these miRNAs also suffer from the limitations of low stability, biodegradation, thermal instability, and other issues. Thus, nanocarrier-based drug delivery for the chemotherapeutic drug delivery in addition to miRNA-based systems have been developed so that existing limitations can be resolved, and enhanced therapeutic outcomes can be achieved. Thus, this review discusses lung cancer’s molecular mechanism, currently approved drugs, and their adverse effects. We also discuss miRNA biosynthesis and pathogenetic role, highlight pre-clinical and clinical evidence for use of miRNA in cancer therapy, and discussed limitations of this therapy. Furthermore, nanocarrier-based drug delivery systems to deliver chemotherapeutic drugs and miRNAs are described in detail. In brief, the present review describes the mechanism and up-to-date possible therapeutic approaches for lung cancer treatment and emphasizes future prospects to bring these novel approaches from bench to bedside. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Anticancer Strategies (Volume II)) </div> ►▼ Show Figures <div ><div ><div ><p>Graphical abstract</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Enhanced Skin Delivery of Therapeutic Peptides Using Spicule-Based Topical Delivery Systems <div > by <span ><div >Chi Zhang</div>, </span><span ><div >Jiwen Duan</div>, </span><span ><div >Yongxiang Huang</div> and </span><span ><div >Ming Chen</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2119; https://doi.org/10.3390/pharmaceutics13122119 - 08 Dec 2021 </div> <div > Abstract <div > This study reports two therapeutic peptides, insulin (INS, as a hydrophilic model peptide) and cyclosporine A (CysA, as a hydrophobic one), that can be administrated through a transdermal or dermal route by using spicule-based topical delivery systems in vitro and in vivo. We [...] Read more. </div> <div > This study reports two therapeutic peptides, insulin (INS, as a hydrophilic model peptide) and cyclosporine A (CysA, as a hydrophobic one), that can be administrated through a transdermal or dermal route by using spicule-based topical delivery systems in vitro and in vivo. We obtained a series of spicules with different shapes and sizes from five kinds of marine sponges and found a good correlation between the skin permeability enhancement induced by these spicules and their aspect ratio <i>L/D</i>. In the case of INS, Sponge <i>Haliclona</i> sp. spicules (SHS) dramatically increased the transdermal flux of INS (457.0 ± 32.3 ng/cm<sup>2</sup>/h) compared to its passive penetration (5.0 ± 2.2 ng/cm<sup>2</sup>/h) in vitro. Further, SHS treatment slowly and gradually reduced blood glucose to 13.1 ± 6.3% of the initial level in 8 h, while subcutaneous injection resulted in a rapid blood glucose reduction to 15.9 ± 1.4% of the initial level in 4 h, followed by a rise back to 75.1 ± 24.0% of the initial level in 8 h. In the case of CysA, SHS in combination with ethosomes (SpEt) significantly (<i>p</i> &lt; 0.05) increased the accumulation of CysA in viable epidermis compared to other groups. Further, SpEt reduced the epidermis thickness by 41.5 ± 9.4% in 7 days, which was significantly more effective than all other groups. Spicule-based topical delivery systems offer promising strategies for delivering therapeutic peptides via a transdermal or dermal route. Full article </div> </div> <div > (This article belongs to the Special Issue Skin Performance of Drug Delivery Systems: Scope, Challenges and Future Research and Regulatory Prospects) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 413 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Abdominoplasty Skin-Based Dressing for Deep Wound Treatment—Evaluation of Different Methods of Preparation on Therapeutic Potential <div > by <span ><div >Dawid Groth</div>, </span><span ><div >Izabela Poplawska</div>, </span><span ><div >Marlena Tynecka</div>, </span><span ><div >Kamil Grubczak</div>, </span><span ><div >Jordan Holl</div>, </span><span ><div >Aleksandra Starosz</div>, </span><span ><div >Adrian Janucik</div>, </span><span ><div >Klaudia Borkowska</div>, </span><span ><div >Dorota Juchniewicz</div>, </span><span ><div >Hady Razak Hady</div>, </span><span ><div >Slawomir Czaban</div>, </span><span ><div >Joanna Reszec</div>, </span><span ><div >Artur Kaminski</div>, </span><span ><div >Tomasz Czech</div>, </span><span ><div >Cezary Kowalewski</div>, </span><span ><div >Piotr Fiedor</div>, </span><span ><div >Zbigniew Zimek</div>, </span><span ><div >Hanna Lewandowska</div>, </span><span ><div >Tomasz Oldak</div>, </span><span ><div >Marcin Moniuszko</div> and </span><span ><div >Andrzej Eljaszewicz</div></span><a ><i >add</i> Show full author list </a><a ><i >remove</i> Hide full author list </a> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2118; https://doi.org/10.3390/pharmaceutics13122118 - 08 Dec 2021 </div> <div > Abstract <div > The management of hard-to-heal wounds is a significant clinical challenge. Acellular dermal matrices (ADMs) have been successfully introduced to enhance the healing process. Here, we aimed to develop protocol for the preparation of novel ADMs from abdominoplasty skin. We used three different decellularization [...] Read more. </div> <div > The management of hard-to-heal wounds is a significant clinical challenge. Acellular dermal matrices (ADMs) have been successfully introduced to enhance the healing process. Here, we aimed to develop protocol for the preparation of novel ADMs from abdominoplasty skin. We used three different decellularization protocols for skin processing, namely, 1M NaCl and sodium dodecyl sulfate (SDS, in ADM1); 2M NaCl and sodium dodecyl sulfate (SDS, in ADM1); and a combination of recombinant trypsin and Triton X-100 (in hADM 3). We assessed the effectiveness of decellularization and ADM’s structure by using histochemical and immunochemical staining. In addition, we evaluated the therapeutic potential of novel ADMs in a murine model of wound healing. Furthermore, targeted transcriptomic profiling of genes associated with wound healing was performed. First, we found that all three proposed methods of decellularization effectively removed cellular components from abdominoplasty skin. We showed, however, significant differences in the presence of class I human leukocyte antigen (HLA class I ABC), Talin 1/2, and chondroitin sulfate proteoglycan (NG2). In addition, we found that protocols, when utilized differentially, influenced the preservation of types I, III, IV, and VII collagens. Finally, we showed that abdominoplasty skin-derived ADMs might serve as an effective and safe option for deep wound treatment. More importantly, our novel dressing (ADM1) improves the kinetics of wound closure and scar maturation in the proliferative and remodeling phases of wound healing. In conclusion, we developed a protocol for abdominoplasty skin decellularization suitable for the preparation of biological dressings. We showed that different decellularization methods affect the purity, structure, and therapeutic properties of ADMs. Full article </div> </div> <div > (This article belongs to the Topic Emerging Material-Based Approaches to Chronic and Infectious Diseases) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >attachment</i> </a> <div > Supplementary material: Supplementary File 1 (ZIP, 2868 KiB) </div> </div> <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessArticle</div> Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions <div > by <span ><div >Vlad Groza</div>, </span><span ><div >Mihai Udrescu</div>, </span><span ><div >Alexandru Bozdog</div> and </span><span ><div >Lucreţia Udrescu</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2117; https://doi.org/10.3390/pharmaceutics13122117 - 08 Dec 2021 </div> <div > Abstract <div > Drug repurposing is a valuable alternative to traditional drug design based on the assumption that medicines have multiple functions. Computer-based techniques use ever-growing drug databases to uncover new drug repurposing hints, which require further validation with in vitro and in vivo experiments. Indeed, [...] Read more. </div> <div > Drug repurposing is a valuable alternative to traditional drug design based on the assumption that medicines have multiple functions. Computer-based techniques use ever-growing drug databases to uncover new drug repurposing hints, which require further validation with in vitro and in vivo experiments. Indeed, such a scientific undertaking can be particularly effective in the case of rare diseases (resources for developing new drugs are scarce) and new diseases such as COVID-19 (designing new drugs require too much time). This paper introduces a new, completely automated computational drug repurposing pipeline based on drug–gene interaction data. We obtained drug–gene interaction data from an earlier version of DrugBank, built a drug–gene interaction network, and projected it as a drug–drug similarity network (DDSN). We then clustered DDSN by optimizing modularity resolution, used the ATC codes distribution within each cluster to identify potential drug repurposing candidates, and verified repurposing hints with the latest DrugBank ATC codes. Finally, using the best modularity resolution found with our method, we applied our pipeline to the latest DrugBank drug–gene interaction data to generate a comprehensive drug repurposing hint list. Full article </div> </div> <div > (This article belongs to the Special Issue In Silico Strategies for Prospective Drug Repositionings) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> <div > <div > <div > <div > <a > <i >get_app</i> </a> </div> <div > <a > <i >subject</i> </a> <div > View online as: Abstract Page Full-Text HTML </div> </div> <div >Open AccessReview</div> Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective <div > by <span ><div >Yongquan Tang</div>, </span><span ><div >Yan Chen</div>, </span><span ><div >Zhe Zhang</div>, </span><span ><div >Bo Tang</div>, </span><span ><div >Zongguang Zhou</div> and </span><span ><div >Haining Chen</div></span> </div> <div > Pharmaceutics <b>2021</b>, 13(12), 2116; https://doi.org/10.3390/pharmaceutics13122116 - 08 Dec 2021 </div> <div > Abstract <div > Cancer stem cells (CSCs) are characterized by intrinsic self-renewal and tumorigenic properties, and play important roles in tumor initiation, progression, and resistance to diverse forms of anticancer therapy. Accordingly, targeting signaling pathways that are critical for CSC maintenance and biofunctions, including the Wnt, [...] Read more. </div> <div > Cancer stem cells (CSCs) are characterized by intrinsic self-renewal and tumorigenic properties, and play important roles in tumor initiation, progression, and resistance to diverse forms of anticancer therapy. Accordingly, targeting signaling pathways that are critical for CSC maintenance and biofunctions, including the Wnt, Notch, Hippo, and Hedgehog signaling cascades, remains a promising therapeutic strategy in multiple cancer types. Furthermore, advances in various cancer omics approaches have largely increased our knowledge of the molecular basis of CSCs, and provided numerous novel targets for anticancer therapy. However, the majority of recently identified targets remain ‘undruggable’ through small-molecule agents, whereas the implications of exogenous RNA interference (RNAi, including siRNA and miRNA) may make it possible to translate our knowledge into therapeutics in a timely manner. With the recent advances of nanomedicine, in vivo delivery of RNAi using elaborate nanoparticles can potently overcome the intrinsic limitations of RNAi alone, as it is rapidly degraded and has unpredictable off-target side effects. Herein, we present an update on the development of RNAi-delivering nanoplatforms in CSC-targeted anticancer therapy and discuss their potential implications in clinical trials. Full article </div> </div> <div > (This article belongs to the Special Issue Novel Nanoparticles for Targeted Delivery of Therapeutic Nucleic Acids) </div> ►▼ Show Figures <div ><div ><div ><p>Figure 1</p></div></div></div> </div> </div> </div> </div> <div > More Articles... </div> </div> </div> </div> <div > <div > <div > <div > <a > Submit to <i>Pharmaceutics</i> </a> Review for Pharmaceutics <div > Share </div> </div> <div > <h2 >Journal Menu</h2> ► ▼ Journal Menu <ul > <li > <ul> <li > Pharmaceutics Home </li> <li > Aims Scope </li> <li > Editorial Board </li> <li > Reviewer Board </li> <li > Topical Advisory Panel </li> <li > Instructions for Authors </li> <li > Special Issues </li> <li > Sections Collections </li> <li > Article Processing Charge </li> <li > Indexing Archiving </li> <li > Most Cited Viewed </li> <li > Journal Statistics </li> <li > Journal History </li> <li > Journal Awards </li> <li > Society Collaborations </li> <li > Conferences </li> <li > Editorial Office </li> </ul> </li> </ul> </div> <h2 >Journal Browser</h2> ► ▼ Journal Browser <div > <div > <ul > <li > <a > <i > arrow_forward_ios </i> Forthcoming issue </a> <a > <i > arrow_forward_ios </i> Current issue </a> </li> <div > <div > <div > <li > Vol. 13 (2021) </li> <li > Vol. 12 (2020) </li> <li > Vol. 11 (2019) </li> <li > Vol. 10 (2018) </li> <li > Vol. 9 (2017) </li> <li > Vol. 8 (2016) </li> <li > Vol. 7 (2015) </li> <li > Vol. 6 (2014) </li> <li > Vol. 5 (2013) </li> <li > Vol. 4 (2012) </li> <li > Vol. 3 (2011) </li> <li > Vol. 2 (2010) </li> <li > Vol. 1 (2009) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div > <div > <h2>Highly Accessed Articles</h2> </div> <div > <div > View More... </div> </div> </div> <div > <div > <h2>Latest Books</h2> </div> <div > <div > More Open Access Books... </div> </div> </div> </div> <div > <div > <div > <h2>E-Mail Alert</h2> </div> </div> <div > <div > <h2>News</h2> </div> <div > <div > 2 December 2021 Meet Us Virtually at the 1st International Electronic Conference on Processes: Processes System Innovation (ECP2022), 17–31 May 2022 </div> <div > 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div > 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div > More News Announcements... </div> </div> </div> <div > <div > <h2>Topics</h2> </div> <div > <div ><div> Topic in Viruses, Biomedicines, Pharmaceuticals, Pharmaceutics, COVID</div> Broad-Spectrum Antiviral Agents Editors-in-Chief: Cheng-Wen Lin, Szu-Hao KungDeadline: 31 December 2021</div> <div ><div> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div ><div> Topic in Biomedicines, Micromachines, Pharmaceutics, Nanomaterials, IJMS</div> Microfluidics Applied in Nanomedicine and Pharmaceutics Deadline: 31 December 2022</div> </div> </div> <div > <div > <h2>Conferences</h2> </div> <div > <div > Announce Your Conference </div> <div > 25–27 May 2022 Polymers 2022 -New Trends in Polymer Science: Health of the Planet, Health of the People</div> <div > More Conferences... </div> </div> </div> <div > <div > <h2>Special Issues</h2> </div> <div > <div > Edit a Special Issue </div> <div ><div> Special Issue in Pharmaceutics</div> Nanocarriers for Drug Delivery and/or Gene Therapy in Cancer Guest Editors: Bianca Gǎlǎţeanu, Marieta CostacheDeadline: 15 December 2021</div> <div ><div> Special Issue in Pharmaceutics</div> Advances in Liposome-Based Drug Delivery Systems Guest Editor: Zacharias SuntresDeadline: 31 December 2021</div> <div ><div> Special Issue in Pharmaceutics</div> Liposomal Drug Delivery Systems Guest Editors: Antonio María Rabasco Álvarez, María Luisa González RodríguezDeadline: 10 January 2022</div> <div ><div> Special Issue in Pharmaceutics</div> In Vivo Predictive Dissolution (iPD): Experimental and Mathematical Approaches and Regulatory Applications Guest Editors: Isabel Gonzalez-Alvarez, Peter LangguthDeadline: 20 January 2022</div> <div > More Special Issues </div> </div> </div> <div > <div > <h2>Topical Collections</h2> </div> <div > <div ><div> Topical Collection in Pharmaceutics</div> Feature Papers in Pharmaceutical Technology Collection Editor: Thierry Vandamme</div> <div ><div> Topical Collection in Pharmaceutics</div> Advanced Pharmaceutical Science and Technology in Korea Collection Editors: Hyo-Kyung Han, Beom-Jin Lee</div> <div ><div> Topical Collection in Pharmaceutics</div> Advanced Pharmaceutical Science and Technology in Estonia Collection Editors: Karin Kogermann, Jana Lass</div> <div ><div> Topical Collection in Pharmaceutics</div> 3D Printing and Bioprinting Applications in Pharmaceutics Collection Editors: Dimitrios A. Lamprou, Eneko Larrañeta Landa</div> <div > More Topical Collections </div> </div> </div> <div > <div > <h2>Jobs in Research</h2> </div> <div > <div > Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div > <div > Pharmaceutics, EISSN 1999-4923, Published by MDPI <span> Disclaimer <div > The statements, opinions and data contained in the journal Pharmaceutics are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div > RSS Content Alert </div> </div> <div > <div > <h3> Further Information </h3> <a > Article Processing Charges </a> <a > Pay an Invoice </a> <a > Open Access Policy </a> <a > Contact MDPI </a> <a > Jobs at MDPI </a> </div> <div > <h3> Guidelines </h3> <a > For Authors </a> <a > For Reviewers </a> <a > For Editors </a> <a > For Librarians </a> <a > For Publishers </a> <a > For Societies </a> </div> <div > <h3> MDPI Initiatives </h3> <a > Sciforum </a> <a > MDPI Books </a> <a > Preprints </a> <a > Scilit </a> <a > SciProfiles </a> <a > Encyclopedia </a> <a > JAMS </a> <a > Proceedings Series </a> </div> <div > <h3> Follow MDPI </h3> <a > LinkedIn </a> <a > Facebook </a> <a > Twitter </a> </div> </div> <div > <div > <div > © 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div > <a > Disclaimer </a> <div > The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a > Terms and Conditions </a> <a > Privacy Policy </a> </div> </div> </div> </div> <div > <div > We use cookies on our website to ensure you get the best experience. Read more about our cookies <a >here</a>. </div> <div > <a >Accept</a> </div> </div> <div > <div > We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div > <a >Never show this again</a> </div> </div> </div> <div > <div > <div > <h2 >Share Link</h2> </div> <div > <a >Copy</a> </div> </div> <a > <i >clear</i> </a> </div> <div > <div > <div > <h2 >Share</h2> </div> </div> <a > <i >clear</i> </a> </div> <a >Back to TopTop</a> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <a class="valid" valid="valid" title="valid: True, node: 5, tag: a, level: 5" node_number="5"> <h2 class="valid" valid="valid" title="valid: True, node: 6, tag: h2, level: 6" node_number="6">25th Anniversary</h2> </a> <a class="valid" valid="valid" title="valid: True, node: 7, tag: a, level: 5" node_number="7"> <h2 class="valid" valid="valid" title="valid: True, node: 8, tag: h2, level: 6" node_number="8">Journals</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 5" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 6" node_number="10"> <h2 class="valid" valid="valid" title="valid: True, node: 11, tag: h2, level: 7" node_number="11">Information</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 12, tag: div, level: 6" node_number="12"> <div class="valid" valid="valid" title="valid: True, node: 13, tag: div, level: 7" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 8" node_number="14"> <a class="valid" valid="valid" title="valid: True, node: 15, tag: a, level: 9" node_number="15">For Authors</a> <a class="valid" valid="valid" title="valid: True, node: 16, tag: a, level: 9" node_number="16">For Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 17, tag: a, level: 9" node_number="17">For Editors</a> <a class="valid" valid="valid" title="valid: True, node: 18, tag: a, level: 9" node_number="18">For Librarians</a> <a class="valid" valid="valid" title="valid: True, node: 19, tag: a, level: 9" node_number="19">For Publishers</a> <a class="valid" valid="valid" title="valid: True, node: 20, tag: a, level: 9" node_number="20">For Societies</a> </div> <div class="valid" valid="valid" title="valid: True, node: 21, tag: div, level: 8" node_number="21"> <a class="valid" valid="valid" title="valid: True, node: 22, tag: a, level: 9" node_number="22">Article Processing Charges</a> <a class="valid" valid="valid" title="valid: True, node: 23, tag: a, level: 9" node_number="23">Open Access Policy</a> <a class="valid" valid="valid" title="valid: True, node: 24, tag: a, level: 9" node_number="24">Institutional Open Access Program</a> <a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 9" node_number="25">Editorial Process</a> <a class="valid" valid="valid" title="valid: True, node: 26, tag: a, level: 9" node_number="26">Awards</a> <a class="valid" valid="valid" title="valid: True, node: 27, tag: a, level: 9" node_number="27">Research and Publication Ethics</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 28, tag: a, level: 5" node_number="28"> <h2 class="valid" valid="valid" title="valid: True, node: 29, tag: h2, level: 6" node_number="29">Author Services</h2> </a> <div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 5" node_number="30"> <div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 6" node_number="31"> <h2 class="valid" valid="valid" title="valid: True, node: 32, tag: h2, level: 7" node_number="32">Initiatives</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 33, tag: div, level: 6" node_number="33"> <div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 7" node_number="34"> <div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 8" node_number="35"> <a class="valid" valid="valid" title="valid: True, node: 36, tag: a, level: 9" node_number="36">Sciforum</a> <a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 9" node_number="37">MDPI Books</a> <a class="valid" valid="valid" title="valid: True, node: 38, tag: a, level: 9" node_number="38">Preprints</a> <a class="valid" valid="valid" title="valid: True, node: 39, tag: a, level: 9" node_number="39">Scilit</a> <a class="valid" valid="valid" title="valid: True, node: 40, tag: a, level: 9" node_number="40">SciProfiles</a> <a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 9" node_number="41">Encyclopedia</a> <a class="valid" valid="valid" title="valid: True, node: 42, tag: a, level: 9" node_number="42">JAMS</a> <a class="valid" valid="valid" title="valid: True, node: 43, tag: a, level: 9" node_number="43">Proceedings Series</a> </div> </div> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 44, tag: a, level: 5" node_number="44"> <h2 class="valid" valid="valid" title="valid: True, node: 45, tag: h2, level: 6" node_number="45">About</h2> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 4" node_number="46"> <a class="valid" valid="valid" title="valid: True, node: 47, tag: a, level: 5" node_number="47">Sign In / Sign Up</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 2" node_number="48"> <h2 class="valid" valid="valid" title="valid: True, node: 49, tag: h2, level: 3" node_number="49">Notice</h2> <a class="valid" valid="valid" title="valid: True, node: 50, tag: a, level: 3" node_number="50"> <i class="valid" valid="valid" title="valid: True, node: 51, tag: i, level: 4" node_number="51">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 2" node_number="52"> <div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 3" node_number="53"> <div class="valid" valid="valid" title="valid: True, node: 54, tag: div, level: 4" node_number="54"> <h2 class="valid" valid="valid" title="valid: True, node: 55, tag: h2, level: 5" node_number="55">Notice</h2> <p class="valid" valid="valid" title="valid: True, node: 56, tag: p, level: 5" node_number="56"> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 57, tag: div, level: 3" node_number="57"> <div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 4" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 5" node_number="59">Continue</a> <a class="valid" valid="valid" title="valid: True, node: 60, tag: a, level: 5" node_number="60">Cancel</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 61, tag: a, level: 3" node_number="61"> <i class="valid" valid="valid" title="valid: True, node: 62, tag: i, level: 4" node_number="62">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 2" node_number="63"> <p class="valid" valid="valid" title="valid: True, node: 64, tag: p, level: 3" node_number="64"> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 2" node_number="65"> <p class="valid" valid="valid" title="valid: True, node: 66, tag: p, level: 3" node_number="66"> Feature Papers represent the most advanced research with significant potential for high impact in the field. Feature Papers are submitted upon individual invitation or recommendation by the scientific editors and undergo peer review prior to publication. </p> <p class="valid" valid="valid" title="valid: True, node: 67, tag: p, level: 3" node_number="67"> The Feature Paper can be either an original research article, a substantial novel research study that often involves several techniques or approaches, or a comprehensive review paper with concise and precise updates on the latest progress in the field that systematically reviews the most exciting advances in scientific literature. This type of paper provides an outlook on future directions of research or possible applications. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 2" node_number="68"> <p class="valid" valid="valid" title="valid: True, node: 69, tag: p, level: 3" node_number="69"> Editor&#8217;s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. </p> </div> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 2" node_number="70"> <div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 3" node_number="71">  </div> <section class="valid" valid="valid" title="valid: True, node: 72, tag: section, level: 3" node_number="72"> <header class="valid" valid="valid" title="valid: True, node: 73, tag: header, level: 4" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 5" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 6" node_number="75"> <div class="valid" valid="valid" title="valid: True, node: 76, tag: div, level: 7" node_number="76"> <ul class="valid" valid="valid" title="valid: True, node: 77, tag: ul, level: 8" node_number="77"> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 9" node_number="78"> <a class="valid" valid="valid" title="valid: True, node: 79, tag: a, level: 10" node_number="79">25th Anniversary</a> </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 9" node_number="80"> <a class="valid" valid="valid" title="valid: True, node: 81, tag: a, level: 10" node_number="81">Journals</a> </li> <li class="valid" valid="valid" title="valid: True, node: 82, tag: li, level: 9" node_number="82"> <a class="valid" valid="valid" title="valid: True, node: 83, tag: a, level: 10" node_number="83">Information</a> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 12" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 13" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 14" node_number="88"> <li title="valid: False, node: 89, tag: li, level: 15" node_number="89"> <a title="valid: False, node: 90, tag: a, level: 16" node_number="90">For Authors</a> </li> <li title="valid: False, node: 91, tag: li, level: 15" node_number="91"> <a title="valid: False, node: 92, tag: a, level: 16" node_number="92">For Reviewers</a> </li> <li title="valid: False, node: 93, tag: li, level: 15" node_number="93"> <a title="valid: False, node: 94, tag: a, level: 16" node_number="94">For Editors</a> </li> <li title="valid: False, node: 95, tag: li, level: 15" node_number="95"> <a title="valid: False, node: 96, tag: a, level: 16" node_number="96">For Librarians</a> </li> <li title="valid: False, node: 97, tag: li, level: 15" node_number="97"> <a title="valid: False, node: 98, tag: a, level: 16" node_number="98">For Publishers</a> </li> <li title="valid: False, node: 99, tag: li, level: 15" node_number="99"> <a title="valid: False, node: 100, tag: a, level: 16" node_number="100">For Societies</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 101, tag: div, level: 13" node_number="101"> <ul class="valid" valid="valid" title="valid: True, node: 102, tag: ul, level: 14" node_number="102"> <li title="valid: False, node: 103, tag: li, level: 15" node_number="103"> <a title="valid: False, node: 104, tag: a, level: 16" node_number="104">Article Processing Charges</a> </li> <li title="valid: False, node: 105, tag: li, level: 15" node_number="105"> <a title="valid: False, node: 106, tag: a, level: 16" node_number="106">Open Access Policy</a> </li> <li title="valid: False, node: 107, tag: li, level: 15" node_number="107"> <a title="valid: False, node: 108, tag: a, level: 16" node_number="108">Institutional Open Access Program</a> </li> <li title="valid: False, node: 109, tag: li, level: 15" node_number="109"> <a title="valid: False, node: 110, tag: a, level: 16" node_number="110">Editorial Process</a> </li> <li title="valid: False, node: 111, tag: li, level: 15" node_number="111"> <a title="valid: False, node: 112, tag: a, level: 16" node_number="112">Awards</a> </li> <li title="valid: False, node: 113, tag: li, level: 15" node_number="113"> <a title="valid: False, node: 114, tag: a, level: 16" node_number="114">Research and Publication Ethics</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 115, tag: li, level: 9" node_number="115"> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 10" node_number="116">Author Services</a> </li> <li class="valid" valid="valid" title="valid: True, node: 117, tag: li, level: 9" node_number="117"> <a class="valid" valid="valid" title="valid: True, node: 118, tag: a, level: 10" node_number="118">Initiatives</a> <ul class="valid" valid="valid" title="valid: True, node: 119, tag: ul, level: 10" node_number="119"> <li class="valid" valid="valid" title="valid: True, node: 120, tag: li, level: 11" node_number="120"> <div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 12" node_number="121"> <div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 13" node_number="122"> <ul class="valid" valid="valid" title="valid: True, node: 123, tag: ul, level: 14" node_number="123"> <li title="valid: False, node: 124, tag: li, level: 15" node_number="124"> <a title="valid: False, node: 125, tag: a, level: 16" node_number="125"> Sciforum </a> </li> <li title="valid: False, node: 126, tag: li, level: 15" node_number="126"> <a title="valid: False, node: 127, tag: a, level: 16" node_number="127"> MDPI Books </a> </li> <li title="valid: False, node: 128, tag: li, level: 15" node_number="128"> <a title="valid: False, node: 129, tag: a, level: 16" node_number="129"> Preprints </a> </li> <li title="valid: False, node: 130, tag: li, level: 15" node_number="130"> <a title="valid: False, node: 131, tag: a, level: 16" node_number="131"> Scilit </a> </li> <li title="valid: False, node: 132, tag: li, level: 15" node_number="132"> <a title="valid: False, node: 133, tag: a, level: 16" node_number="133"> SciProfiles </a> </li> <li title="valid: False, node: 134, tag: li, level: 15" node_number="134"> <a title="valid: False, node: 135, tag: a, level: 16" node_number="135"> Encyclopedia </a> </li> <li title="valid: False, node: 136, tag: li, level: 15" node_number="136"> <a title="valid: False, node: 137, tag: a, level: 16" node_number="137"> JAMS </a> </li> <li title="valid: False, node: 138, tag: li, level: 15" node_number="138"> <a title="valid: False, node: 139, tag: a, level: 16" node_number="139"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="valid" valid="valid" title="valid: True, node: 140, tag: li, level: 9" node_number="140"> <a class="valid" valid="valid" title="valid: True, node: 141, tag: a, level: 10" node_number="141">About</a> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 7" node_number="142"> <div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 8" node_number="143"> <a class="valid" valid="valid" title="valid: True, node: 144, tag: a, level: 9" node_number="144">Sign In / Sign Up</a> <a class="valid" valid="valid" title="valid: True, node: 145, tag: a, level: 9" node_number="145">Submit</a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 146, tag: div, level: 5" node_number="146"> <div class="valid" valid="valid" title="valid: True, node: 147, tag: div, level: 6" node_number="147"> <div class="valid" valid="valid" title="valid: True, node: 148, tag: div, level: 7" node_number="148"> <div class="valid" valid="valid" title="valid: True, node: 149, tag: div, level: 8" node_number="149"> <a class="valid" valid="valid" title="valid: True, node: 150, tag: a, level: 9" node_number="150"> Covered in: PubMed </a> </div></div> <div class="valid" valid="valid" title="valid: True, node: 151, tag: div, level: 7" node_number="151"> <div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 8" node_number="152"> <a class="valid" valid="valid" title="valid: True, node: 153, tag: a, level: 9" node_number="153"> IMPACTFACTOR 6.321 </a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 154, tag: div, level: 6" node_number="154"> Journals </div> <div class="valid" valid="valid" title="valid: True, node: 155, tag: div, level: 6" node_number="155"> Pharmaceutics </div> </div> </header> <div class="valid" valid="valid" title="valid: True, node: 156, tag: div, level: 4" node_number="156"> <div class="valid" valid="valid" title="valid: True, node: 157, tag: div, level: 5" node_number="157"> <div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 6" node_number="158"> <div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 7" node_number="159"> <div class="valid" valid="valid" title="valid: True, node: 160, tag: div, level: 8" node_number="160"> <h2 class="valid" valid="valid" title="valid: True, node: 161, tag: h2, level: 9" node_number="161">Journal Description</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 162, tag: div, level: 8" node_number="162"> <div class="valid" valid="valid" title="valid: True, node: 163, tag: div, level: 9" node_number="163"> <h1 class="valid" valid="valid" title="valid: True, node: 164, tag: h1, level: 10" node_number="164"> Pharmaceutics </h1> <div class="valid" valid="valid" title="valid: True, node: 165, tag: div, level: 10" node_number="165"> Pharmaceutics is a <a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 11" node_number="166">peer-reviewed</a>, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published&#160;monthly online by MDPI. <a class="valid" valid="valid" title="valid: True, node: 167, tag: a, level: 11" node_number="167">The Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG)</a>, <a class="valid" valid="valid" title="valid: True, node: 168, tag: a, level: 11" node_number="168">Pharmaceutical Solid State Research Cluster (PSSRC)</a>,&#160;<a class="valid" valid="valid" title="valid: True, node: 169, tag: a, level: 11" node_number="169">Academy of Pharmaceutical Sciences (APS)</a> and&#160;<a class="valid" valid="valid" title="valid: True, node: 170, tag: a, level: 11" node_number="170">Korean Society of Pharmaceutical Sciences and Technology (KSPST)</a> are affiliated with Pharmaceutics and their members receive a discount on the article processing charges. <ul class="valid" valid="valid" title="valid: True, node: 171, tag: ul, level: 11" node_number="171"> <li class="valid" valid="valid" title="valid: True, node: 172, tag: li, level: 12" node_number="172">Open Access&#8212; free for readers, with <a class="valid" valid="valid" title="valid: True, node: 173, tag: a, level: 13" node_number="173">article processing charges (APC)</a> paid by authors or their institutions.</li> <li class="valid" valid="valid" title="valid: True, node: 174, tag: li, level: 12" node_number="174">High Visibility: indexed&#160;within <a class="valid" valid="valid" title="valid: True, node: 175, tag: a, level: 13" node_number="175">Scopus</a>, <a class="valid" valid="valid" title="valid: True, node: 176, tag: a, level: 13" node_number="176">SCIE (Web of Science)</a>, <a class="valid" valid="valid" title="valid: True, node: 177, tag: a, level: 13" node_number="177">PubMed</a>, <a class="valid" valid="valid" title="valid: True, node: 178, tag: a, level: 13" node_number="178">PMC</a>, <a class="valid" valid="valid" title="valid: True, node: 179, tag: a, level: 13" node_number="179">Embase</a>, <a class="valid" valid="valid" title="valid: True, node: 180, tag: a, level: 13" node_number="180">CAPlus / SciFinder</a>, and many <a class="valid" valid="valid" title="valid: True, node: 181, tag: a, level: 13" node_number="181">other databases</a>.</li> <li class="valid" valid="valid" title="valid: True, node: 182, tag: li, level: 12" node_number="182">Journal Rank:&#160;JCR&#160;- Q1 (Pharmacology Pharmacy) /&#160;CiteScore&#160;- Q2 (Pharmaceutical Science)</li> <li class="valid" valid="valid" title="valid: True, node: 183, tag: li, level: 12" node_number="183">Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 13.5 days after submission; acceptance to publication is undertaken in 3.7 days (median values for papers published in this journal in the first half of 2021).</li> <li class="valid" valid="valid" title="valid: True, node: 184, tag: li, level: 12" node_number="184">Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.</li> <li class="valid" valid="valid" title="valid: True, node: 185, tag: li, level: 12" node_number="185">Companion journal: Future Pharmacology</li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 186, tag: div, level: 10" node_number="186"> Impact Factor: 6.321 (2020) ; 5-Year Impact Factor: 6.734 (2020) </div> <div class="valid" valid="valid" title="valid: True, node: 187, tag: div, level: 10" node_number="187"> <a class="valid" valid="valid" title="valid: True, node: 188, tag: a, level: 11" node_number="188"> <i class="valid" valid="valid" title="valid: True, node: 189, tag: i, level: 12" node_number="189">subject</i> Imprint Information </a> <a class="valid" valid="valid" title="valid: True, node: 190, tag: a, level: 11" node_number="190"> <i class="valid" valid="valid" title="valid: True, node: 191, tag: i, level: 12" node_number="191">get_app</i> Journal Flyer </a> <a class="valid" valid="valid" title="valid: True, node: 192, tag: a, level: 11" node_number="192"> Open Access </a> ISSN: 1999-4923 </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 193, tag: div, level: 7" node_number="193"> <div class="valid" valid="valid" title="valid: True, node: 194, tag: div, level: 8" node_number="194"> <h2 class="valid" valid="valid" title="valid: True, node: 195, tag: h2, level: 9" node_number="195">Latest Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 196, tag: div, level: 8" node_number="196"> <div class="valid" valid="valid" title="valid: True, node: 197, tag: div, level: 9" node_number="197"> <div class="valid" valid="valid" title="valid: True, node: 198, tag: div, level: 10" node_number="198"> <div class="valid" valid="valid" title="valid: True, node: 199, tag: div, level: 11" node_number="199"> <div class="valid" valid="valid" title="valid: True, node: 200, tag: div, level: 12" node_number="200"> <a class="valid" valid="valid" title="valid: True, node: 201, tag: a, level: 13" node_number="201"> <i class="valid" valid="valid" title="valid: True, node: 202, tag: i, level: 14" node_number="202">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 203, tag: div, level: 12" node_number="203"> <a class="valid" valid="valid" title="valid: True, node: 204, tag: a, level: 13" node_number="204"> <i class="valid" valid="valid" title="valid: True, node: 205, tag: i, level: 14" node_number="205">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 206, tag: div, level: 13" node_number="206"> View online as: <a class="valid" valid="valid" title="valid: True, node: 207, tag: a, level: 14" node_number="207">Abstract Page</a> <a class="valid" valid="valid" title="valid: True, node: 208, tag: a, level: 14" node_number="208">Full-Text HTML</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 209, tag: div, level: 12" node_number="209">Open AccessArticle</div> Use of Microfluidic Capillary Electrophoresis for the Determination of Multi-Component Protein Adsorption Isotherms: Application to High-Throughput Analysis for Hydrophobic Interaction Chromatography <div class="valid" valid="valid" title="valid: True, node: 210, tag: div, level: 12" node_number="210"> by <span class="valid" valid="valid" title="valid: True, node: 211, tag: span, level: 13" node_number="211"><div class="valid" valid="valid" title="valid: True, node: 212, tag: div, level: 14" node_number="212">Elena Lietta</div>, </span><span class="valid" valid="valid" title="valid: True, node: 213, tag: span, level: 13" node_number="213"><div class="valid" valid="valid" title="valid: True, node: 214, tag: div, level: 14" node_number="214">Alessandro Pieri</div>, </span><span class="valid" valid="valid" title="valid: True, node: 215, tag: span, level: 13" node_number="215"><div class="valid" valid="valid" title="valid: True, node: 216, tag: div, level: 14" node_number="216">Elisa Innocenti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 217, tag: span, level: 13" node_number="217"><div class="valid" valid="valid" title="valid: True, node: 218, tag: div, level: 14" node_number="218">Roberto Pisano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 219, tag: span, level: 13" node_number="219"><div class="valid" valid="valid" title="valid: True, node: 220, tag: div, level: 14" node_number="220">Marco Vanni</div> and </span><span class="valid" valid="valid" title="valid: True, node: 221, tag: span, level: 13" node_number="221"><div class="valid" valid="valid" title="valid: True, node: 222, tag: div, level: 14" node_number="222">Antonello A. Barresi</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 223, tag: div, level: 12" node_number="223"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 224, tag: b, level: 13" node_number="224">2021</b>, 13(12), 2135; https://doi.org/10.3390/pharmaceutics13122135 (registering&#160;DOI) - 11 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 225, tag: div, level: 12" node_number="225"> Abstract <div class="valid" valid="valid" title="valid: True, node: 226, tag: div, level: 13" node_number="226"> Chromatography is a widely used separation process for purification of biopharmaceuticals that is able to obtain high purities and concentrations. The phenomena that occur during separation, mass transfer and adsorption are quite complex. To better understand these phenomena and their mechanisms, multi-component adsorption [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 227, tag: div, level: 13" node_number="227"> Chromatography is a widely used separation process for purification of biopharmaceuticals that is able to obtain high purities and concentrations. The phenomena that occur during separation, mass transfer and adsorption are quite complex. To better understand these phenomena and their mechanisms, multi-component adsorption isotherms must be investigated. High-throughput methodologies are a very powerful tool to determine adsorption isotherms and they waste very small amounts of sample and chemicals, but the quantification of component concentrations is a real bottleneck in multi-component isotherm determination. The behavior of bovine serum albumin, <i class="valid" valid="valid" title="valid: True, node: 228, tag: i, level: 14" node_number="228">Corynebacterium diphtheriae</i> CRM<sub class="valid" valid="valid" title="valid: True, node: 229, tag: sub, level: 14" node_number="229">197</sub> protein and lysozyme, selected as model proteins in binary mixtures with hydrophobic resin, is investigated here. In this work we propose a new method for determining multi-component adsorption isotherms using high-throughput experiments with filter plates, by exploiting microfluidic capillary electrophoresis. The precision and accuracy of the microfluidic capillary electrophoresis platform were evaluated in order to assess the procedure; they were both found to be high and the procedure is thus reliable in determining adsorption isotherms for binary mixtures. Multi-component adsorption isotherms were determined with a totally high-throughput procedure that turned out to be a very fast and powerful tool. The same procedure can be applied to every kind of high-throughput screening. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 230, tag: div, level: 12" node_number="230"> (This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 231, tag: div, level: 12" node_number="231"><div class="valid" valid="valid" title="valid: True, node: 232, tag: div, level: 13" node_number="232"><div class="valid" valid="valid" title="valid: True, node: 233, tag: div, level: 14" node_number="233"><p title="valid: False, node: 234, tag: p, level: 15" node_number="234">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 235, tag: div, level: 9" node_number="235"> <div class="valid" valid="valid" title="valid: True, node: 236, tag: div, level: 10" node_number="236"> <div class="valid" valid="valid" title="valid: True, node: 237, tag: div, level: 11" node_number="237"> <div class="valid" valid="valid" title="valid: True, node: 238, tag: div, level: 12" node_number="238"> <div class="valid" valid="valid" title="valid: True, node: 239, tag: div, level: 13" node_number="239"> <a class="valid" valid="valid" title="valid: True, node: 240, tag: a, level: 14" node_number="240"> <i title="valid: False, node: 241, tag: i, level: 15" node_number="241">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 242, tag: div, level: 13" node_number="242"> <a class="valid" valid="valid" title="valid: True, node: 243, tag: a, level: 14" node_number="243"> <i title="valid: False, node: 244, tag: i, level: 15" node_number="244">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 245, tag: div, level: 14" node_number="245"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 246, tag: div, level: 13" node_number="246">Open AccessArticle</div> Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines <div class="valid" valid="valid" title="valid: True, node: 247, tag: div, level: 13" node_number="247"> by <span class="valid" valid="valid" title="valid: True, node: 248, tag: span, level: 14" node_number="248"><div title="valid: False, node: 249, tag: div, level: 15" node_number="249">Aytug Kara</div>, </span><span class="valid" valid="valid" title="valid: True, node: 250, tag: span, level: 14" node_number="250"><div title="valid: False, node: 251, tag: div, level: 15" node_number="251">Athina Vassiliadou</div>, </span><span class="valid" valid="valid" title="valid: True, node: 252, tag: span, level: 14" node_number="252"><div title="valid: False, node: 253, tag: div, level: 15" node_number="253">Baris Ongoren</div>, </span><span class="valid" valid="valid" title="valid: True, node: 254, tag: span, level: 14" node_number="254"><div title="valid: False, node: 255, tag: div, level: 15" node_number="255">William Keeble</div>, </span><span class="valid" valid="valid" title="valid: True, node: 256, tag: span, level: 14" node_number="256"><div title="valid: False, node: 257, tag: div, level: 15" node_number="257">Richard Hing</div>, </span><span class="valid" valid="valid" title="valid: True, node: 258, tag: span, level: 14" node_number="258"><div title="valid: False, node: 259, tag: div, level: 15" node_number="259">Aikaterini Lalatsa</div> and </span><span class="valid" valid="valid" title="valid: True, node: 260, tag: span, level: 14" node_number="260"><div title="valid: False, node: 261, tag: div, level: 15" node_number="261">Dolores R. Serrano</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 262, tag: div, level: 13" node_number="262"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 263, tag: b, level: 14" node_number="263">2021</b>, 13(12), 2134; https://doi.org/10.3390/pharmaceutics13122134 (registering&#160;DOI) - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 264, tag: div, level: 13" node_number="264"> Abstract <div class="valid" valid="valid" title="valid: True, node: 265, tag: div, level: 14" node_number="265"> Currently, there is an unmet need to manufacture nanomedicines in a continuous and controlled manner. Three-dimensional (3D) printed microfluidic chips are an alternative to conventional PDMS chips as they can be easily designed and manufactured to allow for customized designs that are able [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 266, tag: div, level: 14" node_number="266"> Currently, there is an unmet need to manufacture nanomedicines in a continuous and controlled manner. Three-dimensional (3D) printed microfluidic chips are an alternative to conventional PDMS chips as they can be easily designed and manufactured to allow for customized designs that are able to reproducibly manufacture nanomedicines at an affordable cost. The manufacturing of microfluidic chips using existing 3D printing technologies remains very challenging because of the intricate geometry of the channels. Here, we demonstrate the manufacture and characterization of nifedipine (NFD) polymeric nanoparticles based on Eudragit L-100 using 3D printed microfluidic chips with 1 mm diameter channels produced with two 3D printing techniques that are widely available, stereolithography (SLA) and fuse deposition modeling (FDM). Fabricated polymeric nanoparticles showed good encapsulation efficiencies and particle sizes in the range of 50&#8211;100 nm. SLA chips possessed better channel resolution and smoother channel surfaces, leading to smaller particle sizes similar to those obtained by conventional manufacturing methods based on solvent evaporation, while SLA manufactured nanoparticles showed a minimal burst effect in acid media compared to nanoparticles fabricated with FDM chips. Three-dimensional printed microfluidic chips are a novel and easily amenable cost-effective strategy to allow for customization of the design process for continuous manufacture of nanomedicines under controlled conditions, enabling easy scale-up and reducing nanomedicine development times, while maintaining high-quality standards. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 267, tag: div, level: 13" node_number="267"> (This article belongs to the Special Issue Advances in Microfluidics for Pharmaceutical Applications) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 268, tag: div, level: 13" node_number="268"><div class="valid" valid="valid" title="valid: True, node: 269, tag: div, level: 14" node_number="269"><div title="valid: False, node: 270, tag: div, level: 15" node_number="270"><p title="valid: False, node: 271, tag: p, level: 16" node_number="271">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 272, tag: div, level: 10" node_number="272"> <div class="valid" valid="valid" title="valid: True, node: 273, tag: div, level: 11" node_number="273"> <div class="valid" valid="valid" title="valid: True, node: 274, tag: div, level: 12" node_number="274"> <div class="valid" valid="valid" title="valid: True, node: 275, tag: div, level: 13" node_number="275"> <a class="valid" valid="valid" title="valid: True, node: 276, tag: a, level: 14" node_number="276"> <i title="valid: False, node: 277, tag: i, level: 15" node_number="277">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 278, tag: div, level: 14" node_number="278"> Supplementary material: Supplementary File 1 (ZIP, 488 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 279, tag: div, level: 13" node_number="279"> <a class="valid" valid="valid" title="valid: True, node: 280, tag: a, level: 14" node_number="280"> <i title="valid: False, node: 281, tag: i, level: 15" node_number="281">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 282, tag: div, level: 13" node_number="282"> <a class="valid" valid="valid" title="valid: True, node: 283, tag: a, level: 14" node_number="283"> <i title="valid: False, node: 284, tag: i, level: 15" node_number="284">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 285, tag: div, level: 14" node_number="285"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 286, tag: div, level: 13" node_number="286">Open AccessArticle</div> Assessment and Modeling of Plasmonic Photothermal Therapy Delivered via a Fiberoptic Microneedle Device Ex Vivo <div class="valid" valid="valid" title="valid: True, node: 287, tag: div, level: 13" node_number="287"> by <span class="valid" valid="valid" title="valid: True, node: 288, tag: span, level: 14" node_number="288"><div title="valid: False, node: 289, tag: div, level: 15" node_number="289">Forhad Akhter</div>, </span><span class="valid" valid="valid" title="valid: True, node: 290, tag: span, level: 14" node_number="290"><div title="valid: False, node: 291, tag: div, level: 15" node_number="291">Santiago Manrique-Bedoya</div>, </span><span class="valid" valid="valid" title="valid: True, node: 292, tag: span, level: 14" node_number="292"><div title="valid: False, node: 293, tag: div, level: 15" node_number="293">Chris Moreau</div>, </span><span class="valid" valid="valid" title="valid: True, node: 294, tag: span, level: 14" node_number="294"><div title="valid: False, node: 295, tag: div, level: 15" node_number="295">Andrea Lynn Smith</div>, </span><span class="valid" valid="valid" title="valid: True, node: 296, tag: span, level: 14" node_number="296"><div title="valid: False, node: 297, tag: div, level: 15" node_number="297">Yusheng Feng</div>, </span><span class="valid" valid="valid" title="valid: True, node: 298, tag: span, level: 14" node_number="298"><div title="valid: False, node: 299, tag: div, level: 15" node_number="299">Kathryn M. Mayer</div> and </span><span class="valid" valid="valid" title="valid: True, node: 300, tag: span, level: 14" node_number="300"><div title="valid: False, node: 301, tag: div, level: 15" node_number="301">R. Lyle Hood</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 302, tag: div, level: 13" node_number="302"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 303, tag: b, level: 14" node_number="303">2021</b>, 13(12), 2133; https://doi.org/10.3390/pharmaceutics13122133 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 304, tag: div, level: 13" node_number="304"> Abstract <div class="valid" valid="valid" title="valid: True, node: 305, tag: div, level: 14" node_number="305"> Plasmonic photothermal therapy (PPTT) has potential as a superior treatment method for pancreatic cancer, a disease with high mortality partially attributable to the currently non-selective treatment options. PPTT utilizes gold nanoparticles infused into a targeted tissue volume and exposed to a specific light [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 306, tag: div, level: 14" node_number="306"> Plasmonic photothermal therapy (PPTT) has potential as a superior treatment method for pancreatic cancer, a disease with high mortality partially attributable to the currently non-selective treatment options. PPTT utilizes gold nanoparticles infused into a targeted tissue volume and exposed to a specific light wavelength to induce selective hyperthermia. The current study focuses on developing this approach within an ex vivo porcine pancreas model via an innovative fiberoptic microneedle device (FMD) for co-delivering light and gold nanoparticles. The effects of laser wavelengths (808 vs. 1064 nm), irradiances (20&#8211;50 mW&#183;mm<sup title="valid: False, node: 307, tag: sup, level: 15" node_number="307">&#8722;2</sup>), and gold nanorod (GNR) concentrations (0.1&#8211;3 nM) on tissue temperature profiles were evaluated to assess and control hyperthermic generation. The GNRs had a peak absorbance at ~800 nm. Results showed that, at 808 nm, photon absorption and subsequent heat generation within tissue without GNRs was 65% less than 1064 nm. The combination of GNRs and 808 nm resulted in a 200% higher temperature rise than the 1064 nm under similar conditions. A computational model was developed to predict the temperature shift and was validated against experimental results with a deviation of &lt;5%. These results show promise for both a predictive model and spatially selective, tunable treatment modality for pancreatic cancer. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 308, tag: div, level: 13" node_number="308"> (This article belongs to the Special Issue Advances in Microneedle-Based Drug Delivery Systems Volume II) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 309, tag: div, level: 13" node_number="309"><div class="valid" valid="valid" title="valid: True, node: 310, tag: div, level: 14" node_number="310"><div title="valid: False, node: 311, tag: div, level: 15" node_number="311"><p title="valid: False, node: 312, tag: p, level: 16" node_number="312">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 313, tag: div, level: 10" node_number="313"> <div class="valid" valid="valid" title="valid: True, node: 314, tag: div, level: 11" node_number="314"> <div class="valid" valid="valid" title="valid: True, node: 315, tag: div, level: 12" node_number="315"> <div class="valid" valid="valid" title="valid: True, node: 316, tag: div, level: 13" node_number="316"> <a class="valid" valid="valid" title="valid: True, node: 317, tag: a, level: 14" node_number="317"> <i title="valid: False, node: 318, tag: i, level: 15" node_number="318">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 319, tag: div, level: 14" node_number="319"> Supplementary material: Supplementary File 1 (ZIP, 558 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 320, tag: div, level: 13" node_number="320"> <a class="valid" valid="valid" title="valid: True, node: 321, tag: a, level: 14" node_number="321"> <i title="valid: False, node: 322, tag: i, level: 15" node_number="322">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 13" node_number="323"> <a class="valid" valid="valid" title="valid: True, node: 324, tag: a, level: 14" node_number="324"> <i title="valid: False, node: 325, tag: i, level: 15" node_number="325">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 326, tag: div, level: 14" node_number="326"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 327, tag: div, level: 13" node_number="327">Open AccessArticle</div> A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice <div class="valid" valid="valid" title="valid: True, node: 328, tag: div, level: 13" node_number="328"> by <span class="valid" valid="valid" title="valid: True, node: 329, tag: span, level: 14" node_number="329"><div title="valid: False, node: 330, tag: div, level: 15" node_number="330">Nouran R. R. Zaid</div>, </span><span class="valid" valid="valid" title="valid: True, node: 331, tag: span, level: 14" node_number="331"><div title="valid: False, node: 332, tag: div, level: 15" node_number="332">Peter Kletting</div>, </span><span class="valid" valid="valid" title="valid: True, node: 333, tag: span, level: 14" node_number="333"><div title="valid: False, node: 334, tag: div, level: 15" node_number="334">Gordon Winter</div>, </span><span class="valid" valid="valid" title="valid: True, node: 335, tag: span, level: 14" node_number="335"><div title="valid: False, node: 336, tag: div, level: 15" node_number="336">Vikas Prasad</div>, </span><span class="valid" valid="valid" title="valid: True, node: 337, tag: span, level: 14" node_number="337"><div title="valid: False, node: 338, tag: div, level: 15" node_number="338">Ambros J. Beer</div> and </span><span class="valid" valid="valid" title="valid: True, node: 339, tag: span, level: 14" node_number="339"><div title="valid: False, node: 340, tag: div, level: 15" node_number="340">Gerhard Glatting</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 341, tag: div, level: 13" node_number="341"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 342, tag: b, level: 14" node_number="342">2021</b>, 13(12), 2132; https://doi.org/10.3390/pharmaceutics13122132 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 343, tag: div, level: 13" node_number="343"> Abstract <div class="valid" valid="valid" title="valid: True, node: 344, tag: div, level: 14" node_number="344"> In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (&#945;-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to address concerns about the [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 345, tag: div, level: 14" node_number="345"> In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (&#945;-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to address concerns about the efficacy and safety of &#945;-PRRT. A murine whole-body physiologically based pharmacokinetic (PBPK) model was developed for <sup title="valid: False, node: 346, tag: sup, level: 15" node_number="346">212</sup>Pb-labeled somatostatin analogs (<sup title="valid: False, node: 347, tag: sup, level: 15" node_number="347">212</sup>Pb-SSTA). The model describes pharmacokinetics of <sup title="valid: False, node: 348, tag: sup, level: 15" node_number="348">212</sup>Pb-SSTA and its decay products, including specific and non-specific glomerular and tubular uptake. Absorbed dose coefficients (ADC) were calculated for bound and unbound radiolabeled SSTA and its decay products. Kidneys received the highest ADC (134 Gy/MBq) among non-target tissues. The alpha-emitting <sup title="valid: False, node: 349, tag: sup, level: 15" node_number="349">212</sup>Po contributes more than 50% to absorbed doses in most tissues. Using this model, it is demonstrated that &#945;-PRRT based on <sup title="valid: False, node: 350, tag: sup, level: 15" node_number="350">212</sup>Pb-SSTA results in lower absorbed doses in non-target tissue than &#945;-PRRT based on <sup title="valid: False, node: 351, tag: sup, level: 15" node_number="351">212</sup>Bi-SSTA for a given kidneys absorbed dose. In both approaches, the energies released in the glomeruli and proximal tubules account for 54% and 46%, respectively, of the total energy absorbed in kidneys. The <sup title="valid: False, node: 352, tag: sup, level: 15" node_number="352">212</sup>Pb-SSTA-PBPK model accelerates the translation from bench to bedside by enabling better experimental design and by improving the understanding of the underlying mechanisms. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 353, tag: div, level: 13" node_number="353"> (This article belongs to the Special Issue Physiologically-Based Pharmacokinetics (PBPK) and Biopharmaceutics (PBBM) Modeling) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 354, tag: div, level: 13" node_number="354"><div class="valid" valid="valid" title="valid: True, node: 355, tag: div, level: 14" node_number="355"><div title="valid: False, node: 356, tag: div, level: 15" node_number="356"><p title="valid: False, node: 357, tag: p, level: 16" node_number="357">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 358, tag: div, level: 10" node_number="358"> <div class="valid" valid="valid" title="valid: True, node: 359, tag: div, level: 11" node_number="359"> <div class="valid" valid="valid" title="valid: True, node: 360, tag: div, level: 12" node_number="360"> <div class="valid" valid="valid" title="valid: True, node: 361, tag: div, level: 13" node_number="361"> <a class="valid" valid="valid" title="valid: True, node: 362, tag: a, level: 14" node_number="362"> <i title="valid: False, node: 363, tag: i, level: 15" node_number="363">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 364, tag: div, level: 13" node_number="364"> <a class="valid" valid="valid" title="valid: True, node: 365, tag: a, level: 14" node_number="365"> <i title="valid: False, node: 366, tag: i, level: 15" node_number="366">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 367, tag: div, level: 14" node_number="367"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 368, tag: div, level: 13" node_number="368">Open AccessReview</div> Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability <div class="valid" valid="valid" title="valid: True, node: 369, tag: div, level: 13" node_number="369"> by <span class="valid" valid="valid" title="valid: True, node: 370, tag: span, level: 14" node_number="370"><div title="valid: False, node: 371, tag: div, level: 15" node_number="371">Daniel Andr&#233;s Real</div>, </span><span class="valid" valid="valid" title="valid: True, node: 372, tag: span, level: 14" node_number="372"><div title="valid: False, node: 373, tag: div, level: 15" node_number="373">Karen Bola&#241;os</div>, </span><span class="valid" valid="valid" title="valid: True, node: 374, tag: span, level: 14" node_number="374"><div title="valid: False, node: 375, tag: div, level: 15" node_number="375">Josefina Priotti</div>, </span><span class="valid" valid="valid" title="valid: True, node: 376, tag: span, level: 14" node_number="376"><div title="valid: False, node: 377, tag: div, level: 15" node_number="377">Nicol&#225;s Yutronic</div>, </span><span class="valid" valid="valid" title="valid: True, node: 378, tag: span, level: 14" node_number="378"><div title="valid: False, node: 379, tag: div, level: 15" node_number="379">Marcelo J. Kogan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 380, tag: span, level: 14" node_number="380"><div title="valid: False, node: 381, tag: div, level: 15" node_number="381">Rodrigo Sierpe</div> and </span><span class="valid" valid="valid" title="valid: True, node: 382, tag: span, level: 14" node_number="382"><div title="valid: False, node: 383, tag: div, level: 15" node_number="383">Orlando Donoso-Gonz&#225;lez</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 384, tag: div, level: 13" node_number="384"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 385, tag: b, level: 14" node_number="385">2021</b>, 13(12), 2131; https://doi.org/10.3390/pharmaceutics13122131 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 386, tag: div, level: 13" node_number="386"> Abstract <div class="valid" valid="valid" title="valid: True, node: 387, tag: div, level: 14" node_number="387"> In drug delivery, one widely used way of overcoming the biopharmaceutical problems present in several active pharmaceutical ingredients, such as poor aqueous solubility, early instability, and low bioavailability, is the formation of inclusion compounds with cyclodextrins (CD). In recent years, the use of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 388, tag: div, level: 14" node_number="388"> In drug delivery, one widely used way of overcoming the biopharmaceutical problems present in several active pharmaceutical ingredients, such as poor aqueous solubility, early instability, and low bioavailability, is the formation of inclusion compounds with cyclodextrins (CD). In recent years, the use of CD derivatives in combination with nanomaterials has shown to be a promising strategy for formulating new, optimized systems. The goals of this review are to give in-depth knowledge and critical appraisal of the main CD-modified or CD-based nanomaterials for drug delivery, such as lipid-based nanocarriers, natural and synthetic polymeric nanocarriers, nanosponges, graphene derivatives, mesoporous silica nanoparticles, plasmonic and magnetic nanoparticles, quantum dots and other miscellaneous systems such as nanovalves, metal-organic frameworks, Janus nanoparticles, and nanofibers. Special attention is given to nanosystems that achieve controlled drug release and increase their bioavailability during in vivo studies. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 389, tag: div, level: 13" node_number="389"> (This article belongs to the Special Issue Cyclodextrins in Drug Delivery) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 390, tag: div, level: 13" node_number="390"><div class="valid" valid="valid" title="valid: True, node: 391, tag: div, level: 14" node_number="391"><div title="valid: False, node: 392, tag: div, level: 15" node_number="392"><p title="valid: False, node: 393, tag: p, level: 16" node_number="393">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 394, tag: div, level: 10" node_number="394"> <div class="valid" valid="valid" title="valid: True, node: 395, tag: div, level: 11" node_number="395"> <div class="valid" valid="valid" title="valid: True, node: 396, tag: div, level: 12" node_number="396"> <div class="valid" valid="valid" title="valid: True, node: 397, tag: div, level: 13" node_number="397"> <a class="valid" valid="valid" title="valid: True, node: 398, tag: a, level: 14" node_number="398"> <i title="valid: False, node: 399, tag: i, level: 15" node_number="399">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 400, tag: div, level: 13" node_number="400"> <a class="valid" valid="valid" title="valid: True, node: 401, tag: a, level: 14" node_number="401"> <i title="valid: False, node: 402, tag: i, level: 15" node_number="402">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 403, tag: div, level: 14" node_number="403"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 404, tag: div, level: 13" node_number="404">Open AccessArticle</div> Low Blue Dose Photodynamic Therapy with Porphyrin-Iron Oxide Nanoparticles Complexes: In Vitro Study on Human Melanoma Cells <div class="valid" valid="valid" title="valid: True, node: 405, tag: div, level: 13" node_number="405"> by <span class="valid" valid="valid" title="valid: True, node: 406, tag: span, level: 14" node_number="406"><div title="valid: False, node: 407, tag: div, level: 15" node_number="407">Simona Nistorescu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 408, tag: span, level: 14" node_number="408"><div title="valid: False, node: 409, tag: div, level: 15" node_number="409">Ana-Maria Udrea</div>, </span><span class="valid" valid="valid" title="valid: True, node: 410, tag: span, level: 14" node_number="410"><div title="valid: False, node: 411, tag: div, level: 15" node_number="411">Madalina Andreea Badea</div>, </span><span class="valid" valid="valid" title="valid: True, node: 412, tag: span, level: 14" node_number="412"><div title="valid: False, node: 413, tag: div, level: 15" node_number="413">Iulia Lungu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 414, tag: span, level: 14" node_number="414"><div title="valid: False, node: 415, tag: div, level: 15" node_number="415">Mihai Boni</div>, </span><span class="valid" valid="valid" title="valid: True, node: 416, tag: span, level: 14" node_number="416"><div title="valid: False, node: 417, tag: div, level: 15" node_number="417">Tatiana Tozar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 418, tag: span, level: 14" node_number="418"><div title="valid: False, node: 419, tag: div, level: 15" node_number="419">Florian Dumitrache</div>, </span><span class="valid" valid="valid" title="valid: True, node: 420, tag: span, level: 14" node_number="420"><div title="valid: False, node: 421, tag: div, level: 15" node_number="421">Valentin-Adrian Maraloiu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 422, tag: span, level: 14" node_number="422"><div title="valid: False, node: 423, tag: div, level: 15" node_number="423">Roua Gabriela Popescu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 424, tag: span, level: 14" node_number="424"><div title="valid: False, node: 425, tag: div, level: 15" node_number="425">Claudiu Fleaca</div>, </span><span class="valid" valid="valid" title="valid: True, node: 426, tag: span, level: 14" node_number="426"><div title="valid: False, node: 427, tag: div, level: 15" node_number="427">Ecaterina Andronescu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 428, tag: span, level: 14" node_number="428"><div title="valid: False, node: 429, tag: div, level: 15" node_number="429">Anca Dinischiotu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 430, tag: span, level: 14" node_number="430"><div title="valid: False, node: 431, tag: div, level: 15" node_number="431">Angela Staicu</div> and </span><span class="valid" valid="valid" title="valid: True, node: 432, tag: span, level: 14" node_number="432"><div title="valid: False, node: 433, tag: div, level: 15" node_number="433">Mihaela Balas</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 434, tag: div, level: 13" node_number="434"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 435, tag: b, level: 14" node_number="435">2021</b>, 13(12), 2130; https://doi.org/10.3390/pharmaceutics13122130 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 436, tag: div, level: 13" node_number="436"> Abstract <div class="valid" valid="valid" title="valid: True, node: 437, tag: div, level: 14" node_number="437"> The purpose of this study was to investigate the effectiveness in photodynamic therapy of iron oxide nanoparticles (&#947;-Fe<sub title="valid: False, node: 438, tag: sub, level: 15" node_number="438">2</sub>O<sub title="valid: False, node: 439, tag: sub, level: 15" node_number="439">3</sub> NPs), synthesized by laser pyrolysis technique, functionalized with 5,10,15,20-(Tetra-4-sulfonatophenyl) porphyrin tetraammonium (TPPS) on human cutaneous melanoma cells, after only 1 min blue [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 440, tag: div, level: 14" node_number="440"> The purpose of this study was to investigate the effectiveness in photodynamic therapy of iron oxide nanoparticles (&#947;-Fe<sub title="valid: False, node: 441, tag: sub, level: 15" node_number="441">2</sub>O<sub title="valid: False, node: 442, tag: sub, level: 15" node_number="442">3</sub> NPs), synthesized by laser pyrolysis technique, functionalized with 5,10,15,20-(Tetra-4-sulfonatophenyl) porphyrin tetraammonium (TPPS) on human cutaneous melanoma cells, after only 1 min blue light exposure. The efficiency of porphyrin loading on the iron oxide nanocarriers was estimated by using absorption and FTIR spectroscopy. The singlet oxygen yield was determined via transient characteristics of singlet oxygen phosphorescence at 1270 nm both for porphyrin functionalized nanoparticles and rose bengal used as standard. The irradiation was performed with a LED (405 nm, 1 mW/cm<sup title="valid: False, node: 443, tag: sup, level: 15" node_number="443">2</sup>) for 1 min after melanoma cells were treated with TPPS functionalized iron oxide nanoparticles (&#947;-Fe<sub title="valid: False, node: 444, tag: sub, level: 15" node_number="444">2</sub>O<sub title="valid: False, node: 445, tag: sub, level: 15" node_number="445">3</sub> NPs_TPPS) and incubated for 24 h. Biological tests revealed a high anticancer effect of &#947;-Fe<sub title="valid: False, node: 446, tag: sub, level: 15" node_number="446">2</sub>O<sub title="valid: False, node: 447, tag: sub, level: 15" node_number="447">3</sub> NPs_TPPS complexes indi-cated by the inhibition of tumor cell proliferation, reduction of cell adhesion, and induction of cell death through ROS generated by TPPS under light exposure. The biological assays were combined with the pharmacokinetic prediction of the porphyrin. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 448, tag: div, level: 13" node_number="448"> (This article belongs to the Special Issue Novel Anticancer Strategies (Volume II)) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 449, tag: div, level: 13" node_number="449"><div class="valid" valid="valid" title="valid: True, node: 450, tag: div, level: 14" node_number="450"><div title="valid: False, node: 451, tag: div, level: 15" node_number="451"><p title="valid: False, node: 452, tag: p, level: 16" node_number="452">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 453, tag: div, level: 10" node_number="453"> <div class="valid" valid="valid" title="valid: True, node: 454, tag: div, level: 11" node_number="454"> <div class="valid" valid="valid" title="valid: True, node: 455, tag: div, level: 12" node_number="455"> <div class="valid" valid="valid" title="valid: True, node: 456, tag: div, level: 13" node_number="456"> <a class="valid" valid="valid" title="valid: True, node: 457, tag: a, level: 14" node_number="457"> <i title="valid: False, node: 458, tag: i, level: 15" node_number="458">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 459, tag: div, level: 13" node_number="459"> <a class="valid" valid="valid" title="valid: True, node: 460, tag: a, level: 14" node_number="460"> <i title="valid: False, node: 461, tag: i, level: 15" node_number="461">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 462, tag: div, level: 14" node_number="462"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 463, tag: div, level: 13" node_number="463">Open AccessReview</div> Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions <div class="valid" valid="valid" title="valid: True, node: 464, tag: div, level: 13" node_number="464"> by <span class="valid" valid="valid" title="valid: True, node: 465, tag: span, level: 14" node_number="465"><div title="valid: False, node: 466, tag: div, level: 15" node_number="466">Elka Touitou</div> and </span><span class="valid" valid="valid" title="valid: True, node: 467, tag: span, level: 14" node_number="467"><div title="valid: False, node: 468, tag: div, level: 15" node_number="468">Hiba Natsheh</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 469, tag: div, level: 13" node_number="469"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 470, tag: b, level: 14" node_number="470">2021</b>, 13(12), 2129; https://doi.org/10.3390/pharmaceutics13122129 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 471, tag: div, level: 13" node_number="471"> Abstract <div class="valid" valid="valid" title="valid: True, node: 472, tag: div, level: 14" node_number="472"> This review focuses on the improved topical treatment of various medical skin conditions by the use of drugs delivered from carriers containing phospholipid soft vesicles. Topical drug delivery has many advantages over other ways of administration, having increased patient compliance, avoiding the first-pass [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 473, tag: div, level: 14" node_number="473"> This review focuses on the improved topical treatment of various medical skin conditions by the use of drugs delivered from carriers containing phospholipid soft vesicles. Topical drug delivery has many advantages over other ways of administration, having increased patient compliance, avoiding the first-pass effect following oral drug administration or not requesting multiple doses administration. However, the skin barrier prevents the access of the applied drug, affecting its therapeutic activity. Carriers containing phospholipid soft vesicles are a new approach to enhance drug delivery into the skin and to improve the treatment outcome. These vesicles contain molecules that have the property to fluidize the phospholipid bilayers generating the soft vesicle and allowing it to penetrate into the deep skin layers. Ethosomes, glycerosomes and transethosomes are soft vesicles containing ethanol, glycerol or a mixture of ethanol and a surfactant, respectively. We review a large number of publications on the research carried out in vitro, in vivo in animal models and in humans in clinical studies, with compositions containing various active molecules for treatment of skin medical conditions including skin infections, skin inflammation, psoriasis, skin cancer, acne vulgaris, hair loss, psoriasis and skin aging. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 474, tag: div, level: 13" node_number="474"> (This article belongs to the Special Issue Women in Pharmaceutics) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 475, tag: div, level: 13" node_number="475"><div class="valid" valid="valid" title="valid: True, node: 476, tag: div, level: 14" node_number="476"><div title="valid: False, node: 477, tag: div, level: 15" node_number="477"><p title="valid: False, node: 478, tag: p, level: 16" node_number="478">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 479, tag: div, level: 10" node_number="479"> <div class="valid" valid="valid" title="valid: True, node: 480, tag: div, level: 11" node_number="480"> <div class="valid" valid="valid" title="valid: True, node: 481, tag: div, level: 12" node_number="481"> <div class="valid" valid="valid" title="valid: True, node: 482, tag: div, level: 13" node_number="482"> <a class="valid" valid="valid" title="valid: True, node: 483, tag: a, level: 14" node_number="483"> <i title="valid: False, node: 484, tag: i, level: 15" node_number="484">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 485, tag: div, level: 14" node_number="485"> Supplementary material: Supplementary File 1 (ZIP, 831 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 486, tag: div, level: 13" node_number="486"> <a class="valid" valid="valid" title="valid: True, node: 487, tag: a, level: 14" node_number="487"> <i title="valid: False, node: 488, tag: i, level: 15" node_number="488">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 489, tag: div, level: 13" node_number="489"> <a class="valid" valid="valid" title="valid: True, node: 490, tag: a, level: 14" node_number="490"> <i title="valid: False, node: 491, tag: i, level: 15" node_number="491">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 492, tag: div, level: 14" node_number="492"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 493, tag: div, level: 13" node_number="493">Open AccessArticle</div> Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing&#8212;A Translational Example for Intensive Care Units <div class="valid" valid="valid" title="valid: True, node: 494, tag: div, level: 13" node_number="494"> by <span class="valid" valid="valid" title="valid: True, node: 495, tag: span, level: 14" node_number="495"><div title="valid: False, node: 496, tag: div, level: 15" node_number="496">Ferdinand Anton Weinelt</div>, </span><span class="valid" valid="valid" title="valid: True, node: 497, tag: span, level: 14" node_number="497"><div title="valid: False, node: 498, tag: div, level: 15" node_number="498">Miriam Songa Stegemann</div>, </span><span class="valid" valid="valid" title="valid: True, node: 499, tag: span, level: 14" node_number="499"><div title="valid: False, node: 500, tag: div, level: 15" node_number="500">Anja Theloe</div>, </span><span class="valid" valid="valid" title="valid: True, node: 501, tag: span, level: 14" node_number="501"><div title="valid: False, node: 502, tag: div, level: 15" node_number="502">Frieder Pf&#228;fflin</div>, </span><span class="valid" valid="valid" title="valid: True, node: 503, tag: span, level: 14" node_number="503"><div title="valid: False, node: 504, tag: div, level: 15" node_number="504">Stephan Achterberg</div>, </span><span class="valid" valid="valid" title="valid: True, node: 505, tag: span, level: 14" node_number="505"><div title="valid: False, node: 506, tag: div, level: 15" node_number="506">Lisa Schmitt</div>, </span><span class="valid" valid="valid" title="valid: True, node: 507, tag: span, level: 14" node_number="507"><div title="valid: False, node: 508, tag: div, level: 15" node_number="508">Wilhelm Huisinga</div>, </span><span class="valid" valid="valid" title="valid: True, node: 509, tag: span, level: 14" node_number="509"><div title="valid: False, node: 510, tag: div, level: 15" node_number="510">Robin Michelet</div>, </span><span class="valid" valid="valid" title="valid: True, node: 511, tag: span, level: 14" node_number="511"><div title="valid: False, node: 512, tag: div, level: 15" node_number="512">Stefanie Hennig</div> and </span><span class="valid" valid="valid" title="valid: True, node: 513, tag: span, level: 14" node_number="513"><div title="valid: False, node: 514, tag: div, level: 15" node_number="514">Charlotte Kloft</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 515, tag: div, level: 13" node_number="515"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 516, tag: b, level: 14" node_number="516">2021</b>, 13(12), 2128; https://doi.org/10.3390/pharmaceutics13122128 - 10 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 517, tag: div, level: 13" node_number="517"> Abstract <div class="valid" valid="valid" title="valid: True, node: 518, tag: div, level: 14" node_number="518"> The prevalence and mortality rates of severe infections are high in intensive care units (ICUs). At the same time, the high pharmacokinetic variability observed in ICU patients increases the risk of inadequate antibiotic drug exposure. Therefore, dosing tailored to specific patient characteristics has [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 519, tag: div, level: 14" node_number="519"> The prevalence and mortality rates of severe infections are high in intensive care units (ICUs). At the same time, the high pharmacokinetic variability observed in ICU patients increases the risk of inadequate antibiotic drug exposure. Therefore, dosing tailored to specific patient characteristics has a high potential to improve outcomes in this vulnerable patient population. This study aimed to develop a tabular dosing decision tool for initial therapy of meropenem integrating hospital-specific, thus far unexploited pathogen susceptibility information. An appropriate meropenem pharmacokinetic model was selected from the literature and evaluated using clinical data. Probability of target attainment (PTA) analysis was conducted for clinically interesting dosing regimens. To inform dosing prior to pathogen identification, the local pathogen-independent mean fraction of response (LPIFR) was calculated based on the observed minimum inhibitory concentrations distribution in the hospital. A simple, tabular, model-informed dosing decision tool was developed for initial meropenem therapy. Dosing recommendations achieving PTA &gt; 90% or LPIFR &gt; 90% for patients with different creatinine clearances were integrated. Based on the experiences during the development process, a generalised workflow for the development of tabular dosing decision tools was derived. The proposed workflow can support the development of model-informed dosing tools for initial therapy of various drugs and hospital-specific conditions. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 520, tag: div, level: 13" node_number="520"> (This article belongs to the Special Issue Model-Informed Precision Dosing) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 521, tag: div, level: 13" node_number="521"><div class="valid" valid="valid" title="valid: True, node: 522, tag: div, level: 14" node_number="522"><div title="valid: False, node: 523, tag: div, level: 15" node_number="523"><p title="valid: False, node: 524, tag: p, level: 16" node_number="524">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 525, tag: div, level: 10" node_number="525"> <div class="valid" valid="valid" title="valid: True, node: 526, tag: div, level: 11" node_number="526"> <div class="valid" valid="valid" title="valid: True, node: 527, tag: div, level: 12" node_number="527"> <div class="valid" valid="valid" title="valid: True, node: 528, tag: div, level: 13" node_number="528"> <a class="valid" valid="valid" title="valid: True, node: 529, tag: a, level: 14" node_number="529"> <i title="valid: False, node: 530, tag: i, level: 15" node_number="530">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 531, tag: div, level: 13" node_number="531"> <a class="valid" valid="valid" title="valid: True, node: 532, tag: a, level: 14" node_number="532"> <i title="valid: False, node: 533, tag: i, level: 15" node_number="533">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 534, tag: div, level: 14" node_number="534"> View online as: Abstract Page </div> </div> <div class="valid" valid="valid" title="valid: True, node: 535, tag: div, level: 13" node_number="535">Open AccessReview</div> Polymeric Materials for Hemostatic Wound Healing <div class="valid" valid="valid" title="valid: True, node: 536, tag: div, level: 13" node_number="536"> by <span class="valid" valid="valid" title="valid: True, node: 537, tag: span, level: 14" node_number="537"><div title="valid: False, node: 538, tag: div, level: 15" node_number="538">Suvash Ghimire</div>, </span><span class="valid" valid="valid" title="valid: True, node: 539, tag: span, level: 14" node_number="539"><div title="valid: False, node: 540, tag: div, level: 15" node_number="540">Pritha Sarkar</div>, </span><span class="valid" valid="valid" title="valid: True, node: 541, tag: span, level: 14" node_number="541"><div title="valid: False, node: 542, tag: div, level: 15" node_number="542">Kasey Rigby</div>, </span><span class="valid" valid="valid" title="valid: True, node: 543, tag: span, level: 14" node_number="543"><div title="valid: False, node: 544, tag: div, level: 15" node_number="544">Aditya Maan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 545, tag: span, level: 14" node_number="545"><div title="valid: False, node: 546, tag: div, level: 15" node_number="546">Santanu Mukherjee</div>, </span><span class="valid" valid="valid" title="valid: True, node: 547, tag: span, level: 14" node_number="547"><div title="valid: False, node: 548, tag: div, level: 15" node_number="548">Kaitlyn E. Crawford</div> and </span><span class="valid" valid="valid" title="valid: True, node: 549, tag: span, level: 14" node_number="549"><div title="valid: False, node: 550, tag: div, level: 15" node_number="550">Kausik Mukhopadhyay</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 551, tag: div, level: 13" node_number="551"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 552, tag: b, level: 14" node_number="552">2021</b>, 13(12), 2127; https://doi.org/10.3390/pharmaceutics13122127 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 553, tag: div, level: 13" node_number="553"> Abstract <div class="valid" valid="valid" title="valid: True, node: 554, tag: div, level: 14" node_number="554"> Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 555, tag: div, level: 14" node_number="555"> Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal or internal hemorrhages are more challenging to treat with regular hemostatic dressings because of deep wounds and points of injury that cannot be located properly. The need to treat trauma wounds from limbs, abdomen, liver, stomach, colon, spleen, arterial, venous, and/or parenchymal hemorrhage accompanied by severe bleeding requires an immediate solution that the first responders can apply to reduce rapid exsanguinations from external wounds, including in military operations. This necessitates the development of a unique, easy-to-use, FDA-approved hemostatic treatment that can deliver the agent in less than 30 s and stop bleeding within the first 1 to 2 min at the point of injury without application of manual pressure on the wounded area. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 556, tag: div, level: 13" node_number="556"> (This article belongs to the Special Issue Advances in Wound Dressings and Materials) </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 557, tag: div, level: 10" node_number="557"> <div class="valid" valid="valid" title="valid: True, node: 558, tag: div, level: 11" node_number="558"> <div class="valid" valid="valid" title="valid: True, node: 559, tag: div, level: 12" node_number="559"> <div class="valid" valid="valid" title="valid: True, node: 560, tag: div, level: 13" node_number="560"> <a class="valid" valid="valid" title="valid: True, node: 561, tag: a, level: 14" node_number="561"> <i title="valid: False, node: 562, tag: i, level: 15" node_number="562">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 563, tag: div, level: 13" node_number="563"> <a class="valid" valid="valid" title="valid: True, node: 564, tag: a, level: 14" node_number="564"> <i title="valid: False, node: 565, tag: i, level: 15" node_number="565">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 566, tag: div, level: 14" node_number="566"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 567, tag: div, level: 13" node_number="567">Open AccessArticle</div> Spin Freezing and Its Impact on Pore Size, Tortuosity and Solid State <div class="valid" valid="valid" title="valid: True, node: 568, tag: div, level: 13" node_number="568"> by <span class="valid" valid="valid" title="valid: True, node: 569, tag: span, level: 14" node_number="569"><div title="valid: False, node: 570, tag: div, level: 15" node_number="570">Joris Lammens</div>, </span><span class="valid" valid="valid" title="valid: True, node: 571, tag: span, level: 14" node_number="571"><div title="valid: False, node: 572, tag: div, level: 15" node_number="572">Niloofar Moazami Goudarzi</div>, </span><span class="valid" valid="valid" title="valid: True, node: 573, tag: span, level: 14" node_number="573"><div title="valid: False, node: 574, tag: div, level: 15" node_number="574">Laurens Leys</div>, </span><span class="valid" valid="valid" title="valid: True, node: 575, tag: span, level: 14" node_number="575"><div title="valid: False, node: 576, tag: div, level: 15" node_number="576">Gust Nuytten</div>, </span><span class="valid" valid="valid" title="valid: True, node: 577, tag: span, level: 14" node_number="577"><div title="valid: False, node: 578, tag: div, level: 15" node_number="578">Pieter-Jan Van Bockstal</div>, </span><span class="valid" valid="valid" title="valid: True, node: 579, tag: span, level: 14" node_number="579"><div title="valid: False, node: 580, tag: div, level: 15" node_number="580">Chris Vervaet</div>, </span><span class="valid" valid="valid" title="valid: True, node: 581, tag: span, level: 14" node_number="581"><div title="valid: False, node: 582, tag: div, level: 15" node_number="582">Matthieu N. Boone</div> and </span><span class="valid" valid="valid" title="valid: True, node: 583, tag: span, level: 14" node_number="583"><div title="valid: False, node: 584, tag: div, level: 15" node_number="584">Thomas De Beer</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 585, tag: div, level: 13" node_number="585"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 586, tag: b, level: 14" node_number="586">2021</b>, 13(12), 2126; https://doi.org/10.3390/pharmaceutics13122126 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 587, tag: div, level: 13" node_number="587"> Abstract <div class="valid" valid="valid" title="valid: True, node: 588, tag: div, level: 14" node_number="588"> Spin freeze-drying, as a part of a continuous freeze-drying technology, is associated with a much higher drying rate and a higher level of process control in comparison with batch freeze-drying. However, the impact of the spin freezing rate on the dried product layer [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 589, tag: div, level: 14" node_number="589"> Spin freeze-drying, as a part of a continuous freeze-drying technology, is associated with a much higher drying rate and a higher level of process control in comparison with batch freeze-drying. However, the impact of the spin freezing rate on the dried product layer characteristics is not well understood at present. This research focuses on the relation between spin-freezing and pore size, pore shape, dried product mass transfer resistance and solid state of the dried product layer. This was thoroughly investigated via high-resolution X-ray micro-computed tomography (&#181;CT), scanning electron microscopy (SEM), thermal imaging and solid state X-ray diffraction (XRD). It was concluded that slow spin-freezing rates resulted in the formation of highly tortuous structures with a high dried-product mass-transfer resistance, while fast spin-freezing rates resulted in lamellar structures with a low tortuosity and low dried-product mass-transfer resistance. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 590, tag: div, level: 13" node_number="590"> (This article belongs to the Special Issue New Trends in Freeze-Drying of Pharmaceutical Products) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 591, tag: div, level: 13" node_number="591"><div class="valid" valid="valid" title="valid: True, node: 592, tag: div, level: 14" node_number="592"><div title="valid: False, node: 593, tag: div, level: 15" node_number="593"><p title="valid: False, node: 594, tag: p, level: 16" node_number="594">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 595, tag: div, level: 10" node_number="595"> <div class="valid" valid="valid" title="valid: True, node: 596, tag: div, level: 11" node_number="596"> <div class="valid" valid="valid" title="valid: True, node: 597, tag: div, level: 12" node_number="597"> <div class="valid" valid="valid" title="valid: True, node: 598, tag: div, level: 13" node_number="598"> <a class="valid" valid="valid" title="valid: True, node: 599, tag: a, level: 14" node_number="599"> <i title="valid: False, node: 600, tag: i, level: 15" node_number="600">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 601, tag: div, level: 14" node_number="601"> Supplementary material: Supplementary File 1 (ZIP, 1150 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 602, tag: div, level: 13" node_number="602"> <a class="valid" valid="valid" title="valid: True, node: 603, tag: a, level: 14" node_number="603"> <i title="valid: False, node: 604, tag: i, level: 15" node_number="604">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 605, tag: div, level: 13" node_number="605"> <a class="valid" valid="valid" title="valid: True, node: 606, tag: a, level: 14" node_number="606"> <i title="valid: False, node: 607, tag: i, level: 15" node_number="607">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 608, tag: div, level: 14" node_number="608"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 609, tag: div, level: 13" node_number="609">Open AccessArticle</div> Submerged Eutectic-Assisted, Solvent-Free Mechanochemical Formation of a Propranolol Salt and Its Other Multicomponent Solids <div class="valid" valid="valid" title="valid: True, node: 610, tag: div, level: 13" node_number="610"> by <span class="valid" valid="valid" title="valid: True, node: 611, tag: span, level: 14" node_number="611"><div title="valid: False, node: 612, tag: div, level: 15" node_number="612">Klaudia Bialek</div>, </span><span class="valid" valid="valid" title="valid: True, node: 613, tag: span, level: 14" node_number="613"><div title="valid: False, node: 614, tag: div, level: 15" node_number="614">Zaneta Wojnarowska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 615, tag: span, level: 14" node_number="615"><div title="valid: False, node: 616, tag: div, level: 15" node_number="616">Marcin Skotnicki</div>, </span><span class="valid" valid="valid" title="valid: True, node: 617, tag: span, level: 14" node_number="617"><div title="valid: False, node: 618, tag: div, level: 15" node_number="618">Brendan Twamley</div>, </span><span class="valid" valid="valid" title="valid: True, node: 619, tag: span, level: 14" node_number="619"><div title="valid: False, node: 620, tag: div, level: 15" node_number="620">Marian Paluch</div> and </span><span class="valid" valid="valid" title="valid: True, node: 621, tag: span, level: 14" node_number="621"><div title="valid: False, node: 622, tag: div, level: 15" node_number="622">Lidia Tajber</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 623, tag: div, level: 13" node_number="623"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 624, tag: b, level: 14" node_number="624">2021</b>, 13(12), 2125; https://doi.org/10.3390/pharmaceutics13122125 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 625, tag: div, level: 13" node_number="625"> Abstract <div class="valid" valid="valid" title="valid: True, node: 626, tag: div, level: 14" node_number="626"> Salt preparation via a solid-state reaction offers a solution to challenges posed by current pharmaceutical research, which include combining development of novel forms of active pharmaceutical ingredients with greener, sustainable synthesis. This work investigated in detail the mechanism of salt formation between propranolol [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 627, tag: div, level: 14" node_number="627"> Salt preparation via a solid-state reaction offers a solution to challenges posed by current pharmaceutical research, which include combining development of novel forms of active pharmaceutical ingredients with greener, sustainable synthesis. This work investigated in detail the mechanism of salt formation between propranolol (PRO) and capric acid (CAP) and explored the solid eutectic phases comprising this salt, propranolol caprate (PRC). The salt structure was solved by X-ray diffraction, and the properties in the crystalline and supercooled states were fully characterised using thermal analysis, nuclear magnetic resonance, Fourier-transform infrared spectroscopy and broadband dielectric spectroscopy (BDS). PRC forms via a submerged eutectic phase composed of PRO and CAP, below room temperature, by mechanochemistry without an extra input of energy. Two other solid eutectic phases are composed of PRC and either CAP or PRO, at 0.28 and 0.82 mol fraction of PRO, respectively. BDS indicated that the supercooled PRC has ionic character, whereas the supercooled PRC-PRO eutectic had predominantly non-ionic properties despite comprising the salt. In conclusion, knowledge of the mechanism of formation of multicomponent systems can help in designing more sustainable pharmaceutical processes. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 628, tag: div, level: 13" node_number="628"> (This article belongs to the Section Physical Pharmacy and Formulation) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 629, tag: div, level: 13" node_number="629"><div class="valid" valid="valid" title="valid: True, node: 630, tag: div, level: 14" node_number="630"><div title="valid: False, node: 631, tag: div, level: 15" node_number="631"><p title="valid: False, node: 632, tag: p, level: 16" node_number="632">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 633, tag: div, level: 10" node_number="633"> <div class="valid" valid="valid" title="valid: True, node: 634, tag: div, level: 11" node_number="634"> <div class="valid" valid="valid" title="valid: True, node: 635, tag: div, level: 12" node_number="635"> <div class="valid" valid="valid" title="valid: True, node: 636, tag: div, level: 13" node_number="636"> <a class="valid" valid="valid" title="valid: True, node: 637, tag: a, level: 14" node_number="637"> <i title="valid: False, node: 638, tag: i, level: 15" node_number="638">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 639, tag: div, level: 14" node_number="639"> Supplementary material: Supplementary File 1 (ZIP, 223 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 640, tag: div, level: 13" node_number="640"> <a class="valid" valid="valid" title="valid: True, node: 641, tag: a, level: 14" node_number="641"> <i title="valid: False, node: 642, tag: i, level: 15" node_number="642">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 643, tag: div, level: 13" node_number="643"> <a class="valid" valid="valid" title="valid: True, node: 644, tag: a, level: 14" node_number="644"> <i title="valid: False, node: 645, tag: i, level: 15" node_number="645">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 646, tag: div, level: 14" node_number="646"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 647, tag: div, level: 13" node_number="647">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 648, tag: a, level: 13" node_number="648">Incorporation of Zinc into Binary SiO<sub class="valid" valid="valid" title="valid: True, node: 649, tag: sub, level: 14" node_number="649">2</sub>-CaO Mesoporous Bioactive Glass Nanoparticles Enhances Anti-Inflammatory and Osteogenic Activities</a> <div class="valid" valid="valid" title="valid: True, node: 650, tag: div, level: 13" node_number="650"> by <span class="valid" valid="valid" title="valid: True, node: 651, tag: span, level: 14" node_number="651"><div title="valid: False, node: 652, tag: div, level: 15" node_number="652">Haishui Sun</div>, </span><span class="valid" valid="valid" title="valid: True, node: 653, tag: span, level: 14" node_number="653"><div title="valid: False, node: 654, tag: div, level: 15" node_number="654">Kai Zheng</div>, </span><span class="valid" valid="valid" title="valid: True, node: 655, tag: span, level: 14" node_number="655"><div title="valid: False, node: 656, tag: div, level: 15" node_number="656">Tian Zhou</div> and </span><span class="valid" valid="valid" title="valid: True, node: 657, tag: span, level: 14" node_number="657"><div title="valid: False, node: 658, tag: div, level: 15" node_number="658">Aldo R. Boccaccini</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 13" node_number="659"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 660, tag: b, level: 14" node_number="660">2021</b>, 13(12), 2124; https://doi.org/10.3390/pharmaceutics13122124 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 661, tag: div, level: 13" node_number="661"> Abstract <div class="valid" valid="valid" title="valid: True, node: 662, tag: div, level: 14" node_number="662"> During the healing and repair of bone defects, uncontrolled inflammatory responses can compromise bone regeneration. Biomaterials with anti-inflammatory activity are favorable for bone tissue regeneration processes. In this work, multifunctional Zn-containing mesoporous bioactive glass nanoparticles (Zn-MBGs) exhibiting favorable osteogenic and anti-inflammatory activities were [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 663, tag: div, level: 14" node_number="663"> During the healing and repair of bone defects, uncontrolled inflammatory responses can compromise bone regeneration. Biomaterials with anti-inflammatory activity are favorable for bone tissue regeneration processes. In this work, multifunctional Zn-containing mesoporous bioactive glass nanoparticles (Zn-MBGs) exhibiting favorable osteogenic and anti-inflammatory activities were produced employing a sol-gel method. Zn-MBGs exhibited a mesoporous spherical shape and nanoscale particle size (100 &#177; 20 nm). They were degradable in cell culture medium, and could release Si, Ca, and Zn in a sustained manner. Zn-MBGs also exhibited a concentration-dependent cellular response. The extract of Zn-MBGs obtained by incubation at 0.1 mg/mL (in culture medium) for 24 h could enhance in vitro mineralization, alkaline phosphatase activity, the expression of osteogenesis-related genes, and the production of intracellular protein osteocalcin of rat bone marrow stromal cells (BMSCs). Moreover, the extract of Zn-MBGs at 0.1 mg/mL could significantly downregulate the expression of inflammatory genes and the production of inducible nitric oxide in RAW 264.7 cells, particularly under stimulation of inflammatory signals interferon-&#947; (IFN-&#947;) and lipopolysaccharide (LPS). Zn-MBGs also inhibited the pro-inflammatory M1 polarization of RAW264.7 cells induced by LPS and IFN-&#947;. In summary, we successfully synthesized Zn-MBGs with concentration-dependent osteogenic and anti-inflammatory activities. Zn-MBGs show their great potential in immunomodulation strategies for bone regeneration, representing a multifunctional biomaterial that can be applied to regenerate bone defects under inflammatory conditions. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 664, tag: div, level: 13" node_number="664"> (This article belongs to the Special Issue Commemorative Issue in Honor of Professor Maria Vallet Reg&#237;: 20 Years of Silica-Based Mesoporous Materials) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 665, tag: div, level: 13" node_number="665"><div class="valid" valid="valid" title="valid: True, node: 666, tag: div, level: 14" node_number="666"><div title="valid: False, node: 667, tag: div, level: 15" node_number="667"><p title="valid: False, node: 668, tag: p, level: 16" node_number="668">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 669, tag: div, level: 10" node_number="669"> <div class="valid" valid="valid" title="valid: True, node: 670, tag: div, level: 11" node_number="670"> <div class="valid" valid="valid" title="valid: True, node: 671, tag: div, level: 12" node_number="671"> <div class="valid" valid="valid" title="valid: True, node: 672, tag: div, level: 13" node_number="672"> <a class="valid" valid="valid" title="valid: True, node: 673, tag: a, level: 14" node_number="673"> <i title="valid: False, node: 674, tag: i, level: 15" node_number="674">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 675, tag: div, level: 14" node_number="675"> Supplementary material: Supplementary File 1 (ZIP, 546 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 676, tag: div, level: 13" node_number="676"> <a class="valid" valid="valid" title="valid: True, node: 677, tag: a, level: 14" node_number="677"> <i title="valid: False, node: 678, tag: i, level: 15" node_number="678">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 679, tag: div, level: 13" node_number="679"> <a class="valid" valid="valid" title="valid: True, node: 680, tag: a, level: 14" node_number="680"> <i title="valid: False, node: 681, tag: i, level: 15" node_number="681">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 682, tag: div, level: 14" node_number="682"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 683, tag: div, level: 13" node_number="683">Open AccessArticle</div> 3D-Printed Coating of Extended-Release Matrix Tablets: Effective Tool for Prevention of Alcohol-Induced Dose Dumping Effect <div class="valid" valid="valid" title="valid: True, node: 684, tag: div, level: 13" node_number="684"> by <span class="valid" valid="valid" title="valid: True, node: 685, tag: span, level: 14" node_number="685"><div title="valid: False, node: 686, tag: div, level: 15" node_number="686">Barbora Skalick&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 687, tag: span, level: 14" node_number="687"><div title="valid: False, node: 688, tag: div, level: 15" node_number="688">Kevin Matzick</div>, </span><span class="valid" valid="valid" title="valid: True, node: 689, tag: span, level: 14" node_number="689"><div title="valid: False, node: 690, tag: div, level: 15" node_number="690">Alena Komersov&#225;</div>, </span><span class="valid" valid="valid" title="valid: True, node: 691, tag: span, level: 14" node_number="691"><div title="valid: False, node: 692, tag: div, level: 15" node_number="692">Roman Svoboda</div>, </span><span class="valid" valid="valid" title="valid: True, node: 693, tag: span, level: 14" node_number="693"><div title="valid: False, node: 694, tag: div, level: 15" node_number="694">Martin Barto&#353;</div> and </span><span class="valid" valid="valid" title="valid: True, node: 695, tag: span, level: 14" node_number="695"><div title="valid: False, node: 696, tag: div, level: 15" node_number="696">Lud&#283;k Hrom&#225;dko</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 697, tag: div, level: 13" node_number="697"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 698, tag: b, level: 14" node_number="698">2021</b>, 13(12), 2123; https://doi.org/10.3390/pharmaceutics13122123 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 699, tag: div, level: 13" node_number="699"> Abstract <div class="valid" valid="valid" title="valid: True, node: 700, tag: div, level: 14" node_number="700"> Tablets used for extended drug release commonly contain large amounts of drugs. The corresponding drug release mechanism thus has to be well-known and invariable under numerous conditions in order to prevent any uncontrolled drug release. Particularly important is the stability and invariability of [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 701, tag: div, level: 14" node_number="701"> Tablets used for extended drug release commonly contain large amounts of drugs. The corresponding drug release mechanism thus has to be well-known and invariable under numerous conditions in order to prevent any uncontrolled drug release. Particularly important is the stability and invariability of the release mechanism in the presence of alcohol due to the possible occurrence of the dose dumping effect. The effect of 3D printing (3DP) coating on the drug release mechanism and the drug release rate was studied as a possible tool for the prevention of the alcohol-induced dose dumping effect. Three types of matrix tablets (hydrophilic, lipophilic, and hydrophilic-lipophilic) were prepared by the direct compression method and coated using 3DP. The commercial filament of polyvinyl alcohol (PVA) and the filament prepared from hypromellose by hot melt extrusion (HME) were used as coating materials. Both coating materials were characterized by SEM, DSC, Raman spectroscopy, and PXRD during particular stages of the processing/coating procedure. The dissolution behavior of the uncoated and coated tablets was studied in the strongly acidic (pH 1.2) and alcoholic (40% of ethanol) dissolution media. The dissolution tests in the alcoholic medium showed that the Affinisol coating was effective in preventing the dose dumping incidence. The dissolution tests in the acidic dissolution media showed that the Affinisol coating can also be useful for the delayed release of active substances. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 702, tag: div, level: 13" node_number="702"> (This article belongs to the Special Issue Advanced Pharmaceutical Research in the Czech Republic) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 13" node_number="703"><div class="valid" valid="valid" title="valid: True, node: 704, tag: div, level: 14" node_number="704"><div title="valid: False, node: 705, tag: div, level: 15" node_number="705"><p title="valid: False, node: 706, tag: p, level: 16" node_number="706">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 707, tag: div, level: 10" node_number="707"> <div class="valid" valid="valid" title="valid: True, node: 708, tag: div, level: 11" node_number="708"> <div class="valid" valid="valid" title="valid: True, node: 709, tag: div, level: 12" node_number="709"> <div class="valid" valid="valid" title="valid: True, node: 710, tag: div, level: 13" node_number="710"> <a class="valid" valid="valid" title="valid: True, node: 711, tag: a, level: 14" node_number="711"> <i title="valid: False, node: 712, tag: i, level: 15" node_number="712">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 713, tag: div, level: 14" node_number="713"> Supplementary material: Supplementary File 1 (ZIP, 1601 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 714, tag: div, level: 13" node_number="714"> <a class="valid" valid="valid" title="valid: True, node: 715, tag: a, level: 14" node_number="715"> <i title="valid: False, node: 716, tag: i, level: 15" node_number="716">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 717, tag: div, level: 13" node_number="717"> <a class="valid" valid="valid" title="valid: True, node: 718, tag: a, level: 14" node_number="718"> <i title="valid: False, node: 719, tag: i, level: 15" node_number="719">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 720, tag: div, level: 14" node_number="720"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 721, tag: div, level: 13" node_number="721">Open AccessArticle</div> An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood&#8211;Brain Barrier in Epileptic Patients <div class="valid" valid="valid" title="valid: True, node: 722, tag: div, level: 13" node_number="722"> by <span class="valid" valid="valid" title="valid: True, node: 723, tag: span, level: 14" node_number="723"><div title="valid: False, node: 724, tag: div, level: 15" node_number="724">Risa Sato</div>, </span><span class="valid" valid="valid" title="valid: True, node: 725, tag: span, level: 14" node_number="725"><div title="valid: False, node: 726, tag: div, level: 15" node_number="726">Kotaro Ohmori</div>, </span><span class="valid" valid="valid" title="valid: True, node: 727, tag: span, level: 14" node_number="727"><div title="valid: False, node: 728, tag: div, level: 15" node_number="728">Mina Umetsu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 729, tag: span, level: 14" node_number="729"><div title="valid: False, node: 730, tag: div, level: 15" node_number="730">Masaki Takao</div>, </span><span class="valid" valid="valid" title="valid: True, node: 731, tag: span, level: 14" node_number="731"><div title="valid: False, node: 732, tag: div, level: 15" node_number="732">Mitsutoshi Tano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 733, tag: span, level: 14" node_number="733"><div title="valid: False, node: 734, tag: div, level: 15" node_number="734">Gerald Grant</div>, </span><span class="valid" valid="valid" title="valid: True, node: 735, tag: span, level: 14" node_number="735"><div title="valid: False, node: 736, tag: div, level: 15" node_number="736">Brenda Porter</div>, </span><span class="valid" valid="valid" title="valid: True, node: 737, tag: span, level: 14" node_number="737"><div title="valid: False, node: 738, tag: div, level: 15" node_number="738">Anthony Bet</div>, </span><span class="valid" valid="valid" title="valid: True, node: 739, tag: span, level: 14" node_number="739"><div title="valid: False, node: 740, tag: div, level: 15" node_number="740">Tetsuya Terasaki</div> and </span><span class="valid" valid="valid" title="valid: True, node: 741, tag: span, level: 14" node_number="741"><div title="valid: False, node: 742, tag: div, level: 15" node_number="742">Yasuo Uchida</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 743, tag: div, level: 13" node_number="743"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 744, tag: b, level: 14" node_number="744">2021</b>, 13(12), 2122; https://doi.org/10.3390/pharmaceutics13122122 - 09 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 745, tag: div, level: 13" node_number="745"> Abstract <div class="valid" valid="valid" title="valid: True, node: 746, tag: div, level: 14" node_number="746"> The purpose of the present study was to quantitatively elucidate the levels of protein expression of anti-epileptic-drug (AED) transporters, metabolizing enzymes and tight junction molecules at the blood&#8211;brain barrier (BBB) in the focal site of epilepsy patients using accurate SWATH (sequential window acquisition [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 747, tag: div, level: 14" node_number="747"> The purpose of the present study was to quantitatively elucidate the levels of protein expression of anti-epileptic-drug (AED) transporters, metabolizing enzymes and tight junction molecules at the blood&#8211;brain barrier (BBB) in the focal site of epilepsy patients using accurate SWATH (sequential window acquisition of all theoretical fragment ion spectra) proteomics. Brain capillaries were isolated from focal sites in six epilepsy patients and five normal brains; tryptic digests were produced and subjected to SWATH analysis. MDR1 and BCRP were significantly downregulated in the epilepsy group compared to the normal group. Out of 16 AED-metabolizing enzymes detected, the protein expression levels of GSTP1, GSTO1, CYP2E1, ALDH1A1, ALDH6A1, ALDH7A1, ALDH9A1 and ADH5 were significantly 2.13-, 6.23-, 2.16-, 2.80-, 1.73-, 1.67-, 2.47- and 2.23-fold greater in the brain capillaries of epileptic patients than those of normal brains, respectively. The protein expression levels of Claudin-5, ZO-1, Catenin alpha-1, beta-1 and delta-1 were significantly lower, 1.97-, 2.51-, 2.44-, 1.90- and 1.63-fold, in the brain capillaries of epileptic patients compared to those of normal brains, respectively. Consistent with these observations, leakage of blood proteins was also observed. These results provide for a better understanding of the therapeutic effect of AEDs and molecular mechanisms of AED resistance in epileptic patients. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 748, tag: div, level: 13" node_number="748"> (This article belongs to the Section Clinical Pharmaceutics) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 749, tag: div, level: 13" node_number="749"><div class="valid" valid="valid" title="valid: True, node: 750, tag: div, level: 14" node_number="750"><div title="valid: False, node: 751, tag: div, level: 15" node_number="751"><p title="valid: False, node: 752, tag: p, level: 16" node_number="752">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 753, tag: div, level: 10" node_number="753"> <div class="valid" valid="valid" title="valid: True, node: 754, tag: div, level: 11" node_number="754"> <div class="valid" valid="valid" title="valid: True, node: 755, tag: div, level: 12" node_number="755"> <div class="valid" valid="valid" title="valid: True, node: 756, tag: div, level: 13" node_number="756"> <a class="valid" valid="valid" title="valid: True, node: 757, tag: a, level: 14" node_number="757"> <i title="valid: False, node: 758, tag: i, level: 15" node_number="758">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 759, tag: div, level: 14" node_number="759"> Supplementary material: Supplementary File 1 (ZIP, 366 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 760, tag: div, level: 13" node_number="760"> <a class="valid" valid="valid" title="valid: True, node: 761, tag: a, level: 14" node_number="761"> <i title="valid: False, node: 762, tag: i, level: 15" node_number="762">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 763, tag: div, level: 13" node_number="763"> <a class="valid" valid="valid" title="valid: True, node: 764, tag: a, level: 14" node_number="764"> <i title="valid: False, node: 765, tag: i, level: 15" node_number="765">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 766, tag: div, level: 14" node_number="766"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 767, tag: div, level: 13" node_number="767">Open AccessArticle</div> <a class="valid" valid="valid" title="valid: True, node: 768, tag: a, level: 13" node_number="768">Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium <i class="valid" valid="valid" title="valid: True, node: 769, tag: i, level: 14" node_number="769">Pseudomonas gessardii</i> M15 against Herpes Simplex Viruses and Coronaviruses</a> <div class="valid" valid="valid" title="valid: True, node: 770, tag: div, level: 13" node_number="770"> by <span class="valid" valid="valid" title="valid: True, node: 771, tag: span, level: 14" node_number="771"><div title="valid: False, node: 772, tag: div, level: 15" node_number="772">Rosa Giugliano</div>, </span><span class="valid" valid="valid" title="valid: True, node: 773, tag: span, level: 14" node_number="773"><div title="valid: False, node: 774, tag: div, level: 15" node_number="774">Carmine Buonocore</div>, </span><span class="valid" valid="valid" title="valid: True, node: 775, tag: span, level: 14" node_number="775"><div title="valid: False, node: 776, tag: div, level: 15" node_number="776">Carla Zannella</div>, </span><span class="valid" valid="valid" title="valid: True, node: 777, tag: span, level: 14" node_number="777"><div title="valid: False, node: 778, tag: div, level: 15" node_number="778">Annalisa Chianese</div>, </span><span class="valid" valid="valid" title="valid: True, node: 779, tag: span, level: 14" node_number="779"><div title="valid: False, node: 780, tag: div, level: 15" node_number="780">Fortunato Palma Esposito</div>, </span><span class="valid" valid="valid" title="valid: True, node: 781, tag: span, level: 14" node_number="781"><div title="valid: False, node: 782, tag: div, level: 15" node_number="782">Pietro Tedesco</div>, </span><span class="valid" valid="valid" title="valid: True, node: 783, tag: span, level: 14" node_number="783"><div title="valid: False, node: 784, tag: div, level: 15" node_number="784">Anna De Filippis</div>, </span><span class="valid" valid="valid" title="valid: True, node: 785, tag: span, level: 14" node_number="785"><div title="valid: False, node: 786, tag: div, level: 15" node_number="786">Massimiliano Galdiero</div>, </span><span class="valid" valid="valid" title="valid: True, node: 787, tag: span, level: 14" node_number="787"><div title="valid: False, node: 788, tag: div, level: 15" node_number="788">Gianluigi Franci</div> and </span><span class="valid" valid="valid" title="valid: True, node: 789, tag: span, level: 14" node_number="789"><div title="valid: False, node: 790, tag: div, level: 15" node_number="790">Donatella de Pascale</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 791, tag: div, level: 13" node_number="791"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 792, tag: b, level: 14" node_number="792">2021</b>, 13(12), 2121; https://doi.org/10.3390/pharmaceutics13122121 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 793, tag: div, level: 13" node_number="793"> Abstract <div class="valid" valid="valid" title="valid: True, node: 794, tag: div, level: 14" node_number="794"> Emerging and re-emerging viruses represent a serious threat to human health at a global level. In particular, enveloped viruses are one of the main causes of viral outbreaks, as recently demonstrated by SARS-CoV-2. An effective strategy to counteract these viruses could be to [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 795, tag: div, level: 14" node_number="795"> Emerging and re-emerging viruses represent a serious threat to human health at a global level. In particular, enveloped viruses are one of the main causes of viral outbreaks, as recently demonstrated by SARS-CoV-2. An effective strategy to counteract these viruses could be to target the envelope by using surface-active compounds. Rhamnolipids (RLs) are microbial biosurfactants displaying a wide range of bioactivities, such as antibacterial, antifungal and antibiofilm, among others. Being of microbial origin, they are environmentally-friendly, biodegradable, and less toxic than synthetic surfactants. In this work, we explored the antiviral activity of the rhamnolipids mixture (M15RL) produced by the Antarctic bacteria <i title="valid: False, node: 796, tag: i, level: 15" node_number="796">Pseudomonas gessardii</i> M15 against viruses belonging to <i title="valid: False, node: 797, tag: i, level: 15" node_number="797">Coronaviridae</i> and <i title="valid: False, node: 798, tag: i, level: 15" node_number="798">Herpesviridae</i> families. In addition, we investigated the rhamnolipids&#8217; mode of action and the possibility of inactivating viruses on treated surfaces. Our results show complete inactivation of HSV-1 and HSV-2 by M15RLs at 6 &#181;g/mL, and of HCoV-229E and SARS-CoV-2 at 25 and 50 &#181;g/mL, respectively. Concerning activity against HCoV-OC43, 80% inhibition of cytopathic effect was recorded, while no activity against naked Poliovirus Type 1 (PV-1) was detectable, suggesting that the antiviral action is mainly directed towards the envelope. In conclusion, we report a significant activity of M15RL against enveloped viruses and demonstrated for the first time the antiviral effect of rhamnolipids against SARS-CoV-2. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 799, tag: div, level: 13" node_number="799"> (This article belongs to the Special Issue Biosurfactants as Multifunctional Ingredients for Emerging Pharmaceutical Formulations) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 800, tag: div, level: 13" node_number="800"><div class="valid" valid="valid" title="valid: True, node: 801, tag: div, level: 14" node_number="801"><div title="valid: False, node: 802, tag: div, level: 15" node_number="802"><p title="valid: False, node: 803, tag: p, level: 16" node_number="803">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 804, tag: div, level: 10" node_number="804"> <div class="valid" valid="valid" title="valid: True, node: 805, tag: div, level: 11" node_number="805"> <div class="valid" valid="valid" title="valid: True, node: 806, tag: div, level: 12" node_number="806"> <div class="valid" valid="valid" title="valid: True, node: 807, tag: div, level: 13" node_number="807"> <a class="valid" valid="valid" title="valid: True, node: 808, tag: a, level: 14" node_number="808"> <i title="valid: False, node: 809, tag: i, level: 15" node_number="809">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 810, tag: div, level: 13" node_number="810"> <a class="valid" valid="valid" title="valid: True, node: 811, tag: a, level: 14" node_number="811"> <i title="valid: False, node: 812, tag: i, level: 15" node_number="812">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 813, tag: div, level: 14" node_number="813"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 814, tag: div, level: 13" node_number="814">Open AccessReview</div> Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review <div class="valid" valid="valid" title="valid: True, node: 815, tag: div, level: 13" node_number="815"> by <span class="valid" valid="valid" title="valid: True, node: 816, tag: span, level: 14" node_number="816"><div title="valid: False, node: 817, tag: div, level: 15" node_number="817">Shadab Md</div>, </span><span class="valid" valid="valid" title="valid: True, node: 818, tag: span, level: 14" node_number="818"><div title="valid: False, node: 819, tag: div, level: 15" node_number="819">Nabil A. Alhakamy</div>, </span><span class="valid" valid="valid" title="valid: True, node: 820, tag: span, level: 14" node_number="820"><div title="valid: False, node: 821, tag: div, level: 15" node_number="821">Shahid Karim</div>, </span><span class="valid" valid="valid" title="valid: True, node: 822, tag: span, level: 14" node_number="822"><div title="valid: False, node: 823, tag: div, level: 15" node_number="823">Gamal A Gabr</div>, </span><span class="valid" valid="valid" title="valid: True, node: 824, tag: span, level: 14" node_number="824"><div title="valid: False, node: 825, tag: div, level: 15" node_number="825">Mohammad Kashif Iqubal</div> and </span><span class="valid" valid="valid" title="valid: True, node: 826, tag: span, level: 14" node_number="826"><div title="valid: False, node: 827, tag: div, level: 15" node_number="827">Samar S. A. Murshid</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 13" node_number="828"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 829, tag: b, level: 14" node_number="829">2021</b>, 13(12), 2120; https://doi.org/10.3390/pharmaceutics13122120 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 830, tag: div, level: 13" node_number="830"> Abstract <div class="valid" valid="valid" title="valid: True, node: 831, tag: div, level: 14" node_number="831"> Lung cancer is one of the most commonly diagnosed cancers and is responsible for a large number of deaths worldwide. The pathogenic mechanism of lung cancer is complex and multifactorial in origin. Thus, various signaling pathways as targets for therapy are being examined, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 832, tag: div, level: 14" node_number="832"> Lung cancer is one of the most commonly diagnosed cancers and is responsible for a large number of deaths worldwide. The pathogenic mechanism of lung cancer is complex and multifactorial in origin. Thus, various signaling pathways as targets for therapy are being examined, and many new drugs are in the pipeline. However, both conventional and target-based drugs have been reported to present significant adverse effects, and both types of drugs can affect the clinical outcome in addition to patient quality of life. Recently, miRNA has been identified as a promising target for lung cancer treatment. Therefore, miRNA mimics, oncomiRs, or miRNA suppressors have been developed and studied for possible anticancer effects. However, these miRNAs also suffer from the limitations of low stability, biodegradation, thermal instability, and other issues. Thus, nanocarrier-based drug delivery for the chemotherapeutic drug delivery in addition to miRNA-based systems have been developed so that existing limitations can be resolved, and enhanced therapeutic outcomes can be achieved. Thus, this review discusses lung cancer&#8217;s molecular mechanism, currently approved drugs, and their adverse effects. We also discuss miRNA biosynthesis and pathogenetic role, highlight pre-clinical and clinical evidence for use of miRNA in cancer therapy, and discussed limitations of this therapy. Furthermore, nanocarrier-based drug delivery systems to deliver chemotherapeutic drugs and miRNAs are described in detail. In brief, the present review describes the mechanism and up-to-date possible therapeutic approaches for lung cancer treatment and emphasizes future prospects to bring these novel approaches from bench to bedside. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 833, tag: div, level: 13" node_number="833"> (This article belongs to the Special Issue Novel Anticancer Strategies (Volume II)) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 834, tag: div, level: 13" node_number="834"><div class="valid" valid="valid" title="valid: True, node: 835, tag: div, level: 14" node_number="835"><div title="valid: False, node: 836, tag: div, level: 15" node_number="836"><p title="valid: False, node: 837, tag: p, level: 16" node_number="837">Graphical abstract</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 838, tag: div, level: 10" node_number="838"> <div class="valid" valid="valid" title="valid: True, node: 839, tag: div, level: 11" node_number="839"> <div class="valid" valid="valid" title="valid: True, node: 840, tag: div, level: 12" node_number="840"> <div class="valid" valid="valid" title="valid: True, node: 841, tag: div, level: 13" node_number="841"> <a class="valid" valid="valid" title="valid: True, node: 842, tag: a, level: 14" node_number="842"> <i title="valid: False, node: 843, tag: i, level: 15" node_number="843">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 844, tag: div, level: 13" node_number="844"> <a class="valid" valid="valid" title="valid: True, node: 845, tag: a, level: 14" node_number="845"> <i title="valid: False, node: 846, tag: i, level: 15" node_number="846">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 847, tag: div, level: 14" node_number="847"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 848, tag: div, level: 13" node_number="848">Open AccessArticle</div> Enhanced Skin Delivery of Therapeutic Peptides Using Spicule-Based Topical Delivery Systems <div class="valid" valid="valid" title="valid: True, node: 849, tag: div, level: 13" node_number="849"> by <span class="valid" valid="valid" title="valid: True, node: 850, tag: span, level: 14" node_number="850"><div title="valid: False, node: 851, tag: div, level: 15" node_number="851">Chi Zhang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 852, tag: span, level: 14" node_number="852"><div title="valid: False, node: 853, tag: div, level: 15" node_number="853">Jiwen Duan</div>, </span><span class="valid" valid="valid" title="valid: True, node: 854, tag: span, level: 14" node_number="854"><div title="valid: False, node: 855, tag: div, level: 15" node_number="855">Yongxiang Huang</div> and </span><span class="valid" valid="valid" title="valid: True, node: 856, tag: span, level: 14" node_number="856"><div title="valid: False, node: 857, tag: div, level: 15" node_number="857">Ming Chen</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 858, tag: div, level: 13" node_number="858"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 859, tag: b, level: 14" node_number="859">2021</b>, 13(12), 2119; https://doi.org/10.3390/pharmaceutics13122119 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 860, tag: div, level: 13" node_number="860"> Abstract <div class="valid" valid="valid" title="valid: True, node: 861, tag: div, level: 14" node_number="861"> This study reports two therapeutic peptides, insulin (INS, as a hydrophilic model peptide) and cyclosporine A (CysA, as a hydrophobic one), that can be administrated through a transdermal or dermal route by using spicule-based topical delivery systems in vitro and in vivo. We [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 862, tag: div, level: 14" node_number="862"> This study reports two therapeutic peptides, insulin (INS, as a hydrophilic model peptide) and cyclosporine A (CysA, as a hydrophobic one), that can be administrated through a transdermal or dermal route by using spicule-based topical delivery systems in vitro and in vivo. We obtained a series of spicules with different shapes and sizes from five kinds of marine sponges and found a good correlation between the skin permeability enhancement induced by these spicules and their aspect ratio <i title="valid: False, node: 863, tag: i, level: 15" node_number="863">L/D</i>. In the case of INS, Sponge <i title="valid: False, node: 864, tag: i, level: 15" node_number="864">Haliclona</i> sp. spicules (SHS) dramatically increased the transdermal flux of INS (457.0 &#177; 32.3 ng/cm<sup title="valid: False, node: 865, tag: sup, level: 15" node_number="865">2</sup>/h) compared to its passive penetration (5.0 &#177; 2.2 ng/cm<sup title="valid: False, node: 866, tag: sup, level: 15" node_number="866">2</sup>/h) in vitro. Further, SHS treatment slowly and gradually reduced blood glucose to 13.1 &#177; 6.3% of the initial level in 8 h, while subcutaneous injection resulted in a rapid blood glucose reduction to 15.9 &#177; 1.4% of the initial level in 4 h, followed by a rise back to 75.1 &#177; 24.0% of the initial level in 8 h. In the case of CysA, SHS in combination with ethosomes (SpEt) significantly (<i title="valid: False, node: 867, tag: i, level: 15" node_number="867">p</i> &lt; 0.05) increased the accumulation of CysA in viable epidermis compared to other groups. Further, SpEt reduced the epidermis thickness by 41.5 &#177; 9.4% in 7 days, which was significantly more effective than all other groups. Spicule-based topical delivery systems offer promising strategies for delivering therapeutic peptides via a transdermal or dermal route. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 868, tag: div, level: 13" node_number="868"> (This article belongs to the Special Issue Skin Performance of Drug Delivery Systems: Scope, Challenges and Future Research and Regulatory Prospects) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 869, tag: div, level: 13" node_number="869"><div class="valid" valid="valid" title="valid: True, node: 870, tag: div, level: 14" node_number="870"><div title="valid: False, node: 871, tag: div, level: 15" node_number="871"><p title="valid: False, node: 872, tag: p, level: 16" node_number="872">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 873, tag: div, level: 10" node_number="873"> <div class="valid" valid="valid" title="valid: True, node: 874, tag: div, level: 11" node_number="874"> <div class="valid" valid="valid" title="valid: True, node: 875, tag: div, level: 12" node_number="875"> <div class="valid" valid="valid" title="valid: True, node: 876, tag: div, level: 13" node_number="876"> <a class="valid" valid="valid" title="valid: True, node: 877, tag: a, level: 14" node_number="877"> <i title="valid: False, node: 878, tag: i, level: 15" node_number="878">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 879, tag: div, level: 14" node_number="879"> Supplementary material: Supplementary File 1 (ZIP, 413 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 880, tag: div, level: 13" node_number="880"> <a class="valid" valid="valid" title="valid: True, node: 881, tag: a, level: 14" node_number="881"> <i title="valid: False, node: 882, tag: i, level: 15" node_number="882">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 883, tag: div, level: 13" node_number="883"> <a class="valid" valid="valid" title="valid: True, node: 884, tag: a, level: 14" node_number="884"> <i title="valid: False, node: 885, tag: i, level: 15" node_number="885">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 886, tag: div, level: 14" node_number="886"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 887, tag: div, level: 13" node_number="887">Open AccessArticle</div> Abdominoplasty Skin-Based Dressing for Deep Wound Treatment&#8212;Evaluation of Different Methods of Preparation on Therapeutic Potential <div class="valid" valid="valid" title="valid: True, node: 888, tag: div, level: 13" node_number="888"> by <span class="valid" valid="valid" title="valid: True, node: 889, tag: span, level: 14" node_number="889"><div title="valid: False, node: 890, tag: div, level: 15" node_number="890">Dawid Groth</div>, </span><span class="valid" valid="valid" title="valid: True, node: 891, tag: span, level: 14" node_number="891"><div title="valid: False, node: 892, tag: div, level: 15" node_number="892">Izabela Poplawska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 893, tag: span, level: 14" node_number="893"><div title="valid: False, node: 894, tag: div, level: 15" node_number="894">Marlena Tynecka</div>, </span><span class="valid" valid="valid" title="valid: True, node: 895, tag: span, level: 14" node_number="895"><div title="valid: False, node: 896, tag: div, level: 15" node_number="896">Kamil Grubczak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 897, tag: span, level: 14" node_number="897"><div title="valid: False, node: 898, tag: div, level: 15" node_number="898">Jordan Holl</div>, </span><span class="valid" valid="valid" title="valid: True, node: 899, tag: span, level: 14" node_number="899"><div title="valid: False, node: 900, tag: div, level: 15" node_number="900">Aleksandra Starosz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 901, tag: span, level: 14" node_number="901"><div title="valid: False, node: 902, tag: div, level: 15" node_number="902">Adrian Janucik</div>, </span><span class="valid" valid="valid" title="valid: True, node: 903, tag: span, level: 14" node_number="903"><div title="valid: False, node: 904, tag: div, level: 15" node_number="904">Klaudia Borkowska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 905, tag: span, level: 14" node_number="905"><div title="valid: False, node: 906, tag: div, level: 15" node_number="906">Dorota Juchniewicz</div>, </span><span class="valid" valid="valid" title="valid: True, node: 907, tag: span, level: 14" node_number="907"><div title="valid: False, node: 908, tag: div, level: 15" node_number="908">Hady Razak Hady</div>, </span><span class="valid" valid="valid" title="valid: True, node: 909, tag: span, level: 14" node_number="909"><div title="valid: False, node: 910, tag: div, level: 15" node_number="910">Slawomir Czaban</div>, </span><span class="valid" valid="valid" title="valid: True, node: 911, tag: span, level: 14" node_number="911"><div title="valid: False, node: 912, tag: div, level: 15" node_number="912">Joanna Reszec</div>, </span><span class="valid" valid="valid" title="valid: True, node: 913, tag: span, level: 14" node_number="913"><div title="valid: False, node: 914, tag: div, level: 15" node_number="914">Artur Kaminski</div>, </span><span class="valid" valid="valid" title="valid: True, node: 915, tag: span, level: 14" node_number="915"><div title="valid: False, node: 916, tag: div, level: 15" node_number="916">Tomasz Czech</div>, </span><span class="valid" valid="valid" title="valid: True, node: 917, tag: span, level: 14" node_number="917"><div title="valid: False, node: 918, tag: div, level: 15" node_number="918">Cezary Kowalewski</div>, </span><span class="valid" valid="valid" title="valid: True, node: 919, tag: span, level: 14" node_number="919"><div title="valid: False, node: 920, tag: div, level: 15" node_number="920">Piotr Fiedor</div>, </span><span class="valid" valid="valid" title="valid: True, node: 921, tag: span, level: 14" node_number="921"><div title="valid: False, node: 922, tag: div, level: 15" node_number="922">Zbigniew Zimek</div>, </span><span class="valid" valid="valid" title="valid: True, node: 923, tag: span, level: 14" node_number="923"><div title="valid: False, node: 924, tag: div, level: 15" node_number="924">Hanna Lewandowska</div>, </span><span class="valid" valid="valid" title="valid: True, node: 925, tag: span, level: 14" node_number="925"><div title="valid: False, node: 926, tag: div, level: 15" node_number="926">Tomasz Oldak</div>, </span><span class="valid" valid="valid" title="valid: True, node: 927, tag: span, level: 14" node_number="927"><div title="valid: False, node: 928, tag: div, level: 15" node_number="928">Marcin Moniuszko</div> and </span><span class="valid" valid="valid" title="valid: True, node: 929, tag: span, level: 14" node_number="929"><div title="valid: False, node: 930, tag: div, level: 15" node_number="930">Andrzej Eljaszewicz</div></span><a class="valid" valid="valid" title="valid: True, node: 931, tag: a, level: 14" node_number="931"><i title="valid: False, node: 932, tag: i, level: 15" node_number="932">add</i> Show full author list </a><a class="valid" valid="valid" title="valid: True, node: 933, tag: a, level: 14" node_number="933"><i title="valid: False, node: 934, tag: i, level: 15" node_number="934">remove</i> Hide full author list </a> </div> <div class="valid" valid="valid" title="valid: True, node: 935, tag: div, level: 13" node_number="935"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 936, tag: b, level: 14" node_number="936">2021</b>, 13(12), 2118; https://doi.org/10.3390/pharmaceutics13122118 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 937, tag: div, level: 13" node_number="937"> Abstract <div class="valid" valid="valid" title="valid: True, node: 938, tag: div, level: 14" node_number="938"> The management of hard-to-heal wounds is a significant clinical challenge. Acellular dermal matrices (ADMs) have been successfully introduced to enhance the healing process. Here, we aimed to develop protocol for the preparation of novel ADMs from abdominoplasty skin. We used three different decellularization [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 939, tag: div, level: 14" node_number="939"> The management of hard-to-heal wounds is a significant clinical challenge. Acellular dermal matrices (ADMs) have been successfully introduced to enhance the healing process. Here, we aimed to develop protocol for the preparation of novel ADMs from abdominoplasty skin. We used three different decellularization protocols for skin processing, namely, 1M NaCl and sodium dodecyl sulfate (SDS, in ADM1); 2M NaCl and sodium dodecyl sulfate (SDS, in ADM1); and a combination of recombinant trypsin and Triton X-100 (in hADM 3). We assessed the effectiveness of decellularization and ADM&#8217;s structure by using histochemical and immunochemical staining. In addition, we evaluated the therapeutic potential of novel ADMs in a murine model of wound healing. Furthermore, targeted transcriptomic profiling of genes associated with wound healing was performed. First, we found that all three proposed methods of decellularization effectively removed cellular components from abdominoplasty skin. We showed, however, significant differences in the presence of class I human leukocyte antigen (HLA class I ABC), Talin 1/2, and chondroitin sulfate proteoglycan (NG2). In addition, we found that protocols, when utilized differentially, influenced the preservation of types I, III, IV, and VII collagens. Finally, we showed that abdominoplasty skin-derived ADMs might serve as an effective and safe option for deep wound treatment. More importantly, our novel dressing (ADM1) improves the kinetics of wound closure and scar maturation in the proliferative and remodeling phases of wound healing. In conclusion, we developed a protocol for abdominoplasty skin decellularization suitable for the preparation of biological dressings. We showed that different decellularization methods affect the purity, structure, and therapeutic properties of ADMs. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 940, tag: div, level: 13" node_number="940"> (This article belongs to the Topic Emerging Material-Based Approaches to Chronic and Infectious Diseases) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 941, tag: div, level: 13" node_number="941"><div class="valid" valid="valid" title="valid: True, node: 942, tag: div, level: 14" node_number="942"><div title="valid: False, node: 943, tag: div, level: 15" node_number="943"><p title="valid: False, node: 944, tag: p, level: 16" node_number="944">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 945, tag: div, level: 10" node_number="945"> <div class="valid" valid="valid" title="valid: True, node: 946, tag: div, level: 11" node_number="946"> <div class="valid" valid="valid" title="valid: True, node: 947, tag: div, level: 12" node_number="947"> <div class="valid" valid="valid" title="valid: True, node: 948, tag: div, level: 13" node_number="948"> <a class="valid" valid="valid" title="valid: True, node: 949, tag: a, level: 14" node_number="949"> <i title="valid: False, node: 950, tag: i, level: 15" node_number="950">attachment</i> </a> <div class="valid" valid="valid" title="valid: True, node: 951, tag: div, level: 14" node_number="951"> Supplementary material: Supplementary File 1 (ZIP, 2868 KiB) </div> </div> <div class="valid" valid="valid" title="valid: True, node: 952, tag: div, level: 13" node_number="952"> <a class="valid" valid="valid" title="valid: True, node: 953, tag: a, level: 14" node_number="953"> <i title="valid: False, node: 954, tag: i, level: 15" node_number="954">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 955, tag: div, level: 13" node_number="955"> <a class="valid" valid="valid" title="valid: True, node: 956, tag: a, level: 14" node_number="956"> <i title="valid: False, node: 957, tag: i, level: 15" node_number="957">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 958, tag: div, level: 14" node_number="958"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 959, tag: div, level: 13" node_number="959">Open AccessArticle</div> Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug&#8211;Gene Interactions <div class="valid" valid="valid" title="valid: True, node: 960, tag: div, level: 13" node_number="960"> by <span class="valid" valid="valid" title="valid: True, node: 961, tag: span, level: 14" node_number="961"><div title="valid: False, node: 962, tag: div, level: 15" node_number="962">Vlad Groza</div>, </span><span class="valid" valid="valid" title="valid: True, node: 963, tag: span, level: 14" node_number="963"><div title="valid: False, node: 964, tag: div, level: 15" node_number="964">Mihai Udrescu</div>, </span><span class="valid" valid="valid" title="valid: True, node: 965, tag: span, level: 14" node_number="965"><div title="valid: False, node: 966, tag: div, level: 15" node_number="966">Alexandru Bozdog</div> and </span><span class="valid" valid="valid" title="valid: True, node: 967, tag: span, level: 14" node_number="967"><div title="valid: False, node: 968, tag: div, level: 15" node_number="968">Lucre&#355;ia Udrescu</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 969, tag: div, level: 13" node_number="969"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 970, tag: b, level: 14" node_number="970">2021</b>, 13(12), 2117; https://doi.org/10.3390/pharmaceutics13122117 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 971, tag: div, level: 13" node_number="971"> Abstract <div class="valid" valid="valid" title="valid: True, node: 972, tag: div, level: 14" node_number="972"> Drug repurposing is a valuable alternative to traditional drug design based on the assumption that medicines have multiple functions. Computer-based techniques use ever-growing drug databases to uncover new drug repurposing hints, which require further validation with in vitro and in vivo experiments. Indeed, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 973, tag: div, level: 14" node_number="973"> Drug repurposing is a valuable alternative to traditional drug design based on the assumption that medicines have multiple functions. Computer-based techniques use ever-growing drug databases to uncover new drug repurposing hints, which require further validation with in vitro and in vivo experiments. Indeed, such a scientific undertaking can be particularly effective in the case of rare diseases (resources for developing new drugs are scarce) and new diseases such as COVID-19 (designing new drugs require too much time). This paper introduces a new, completely automated computational drug repurposing pipeline based on drug&#8211;gene interaction data. We obtained drug&#8211;gene interaction data from an earlier version of DrugBank, built a drug&#8211;gene interaction network, and projected it as a drug&#8211;drug similarity network (DDSN). We then clustered DDSN by optimizing modularity resolution, used the ATC codes distribution within each cluster to identify potential drug repurposing candidates, and verified repurposing hints with the latest DrugBank ATC codes. Finally, using the best modularity resolution found with our method, we applied our pipeline to the latest DrugBank drug&#8211;gene interaction data to generate a comprehensive drug repurposing hint list. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 974, tag: div, level: 13" node_number="974"> (This article belongs to the Special Issue In Silico Strategies for Prospective Drug Repositionings) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 13" node_number="975"><div class="valid" valid="valid" title="valid: True, node: 976, tag: div, level: 14" node_number="976"><div title="valid: False, node: 977, tag: div, level: 15" node_number="977"><p title="valid: False, node: 978, tag: p, level: 16" node_number="978">Figure 1</p></div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 979, tag: div, level: 10" node_number="979"> <div class="valid" valid="valid" title="valid: True, node: 980, tag: div, level: 11" node_number="980"> <div class="valid" valid="valid" title="valid: True, node: 981, tag: div, level: 12" node_number="981"> <div class="valid" valid="valid" title="valid: True, node: 982, tag: div, level: 13" node_number="982"> <a class="valid" valid="valid" title="valid: True, node: 983, tag: a, level: 14" node_number="983"> <i title="valid: False, node: 984, tag: i, level: 15" node_number="984">get_app</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 985, tag: div, level: 13" node_number="985"> <a class="valid" valid="valid" title="valid: True, node: 986, tag: a, level: 14" node_number="986"> <i title="valid: False, node: 987, tag: i, level: 15" node_number="987">subject</i> </a> <div class="valid" valid="valid" title="valid: True, node: 988, tag: div, level: 14" node_number="988"> View online as: Abstract Page Full-Text HTML </div> </div> <div class="valid" valid="valid" title="valid: True, node: 989, tag: div, level: 13" node_number="989">Open AccessReview</div> Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective <div class="valid" valid="valid" title="valid: True, node: 990, tag: div, level: 13" node_number="990"> by <span class="valid" valid="valid" title="valid: True, node: 991, tag: span, level: 14" node_number="991"><div title="valid: False, node: 992, tag: div, level: 15" node_number="992">Yongquan Tang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 993, tag: span, level: 14" node_number="993"><div title="valid: False, node: 994, tag: div, level: 15" node_number="994">Yan Chen</div>, </span><span class="valid" valid="valid" title="valid: True, node: 995, tag: span, level: 14" node_number="995"><div title="valid: False, node: 996, tag: div, level: 15" node_number="996">Zhe Zhang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 997, tag: span, level: 14" node_number="997"><div title="valid: False, node: 998, tag: div, level: 15" node_number="998">Bo Tang</div>, </span><span class="valid" valid="valid" title="valid: True, node: 999, tag: span, level: 14" node_number="999"><div title="valid: False, node: 1000, tag: div, level: 15" node_number="1000">Zongguang Zhou</div> and </span><span class="valid" valid="valid" title="valid: True, node: 1001, tag: span, level: 14" node_number="1001"><div title="valid: False, node: 1002, tag: div, level: 15" node_number="1002">Haining Chen</div></span> </div> <div class="valid" valid="valid" title="valid: True, node: 1003, tag: div, level: 13" node_number="1003"> Pharmaceutics <b class="valid" valid="valid" title="valid: True, node: 1004, tag: b, level: 14" node_number="1004">2021</b>, 13(12), 2116; https://doi.org/10.3390/pharmaceutics13122116 - 08 Dec 2021 </div> <div class="valid" valid="valid" title="valid: True, node: 1005, tag: div, level: 13" node_number="1005"> Abstract <div class="valid" valid="valid" title="valid: True, node: 1006, tag: div, level: 14" node_number="1006"> Cancer stem cells (CSCs) are characterized by intrinsic self-renewal and tumorigenic properties, and play important roles in tumor initiation, progression, and resistance to diverse forms of anticancer therapy. Accordingly, targeting signaling pathways that are critical for CSC maintenance and biofunctions, including the Wnt, [...] Read more. </div> <div class="valid" valid="valid" title="valid: True, node: 1007, tag: div, level: 14" node_number="1007"> Cancer stem cells (CSCs) are characterized by intrinsic self-renewal and tumorigenic properties, and play important roles in tumor initiation, progression, and resistance to diverse forms of anticancer therapy. Accordingly, targeting signaling pathways that are critical for CSC maintenance and biofunctions, including the Wnt, Notch, Hippo, and Hedgehog signaling cascades, remains a promising therapeutic strategy in multiple cancer types. Furthermore, advances in various cancer omics approaches have largely increased our knowledge of the molecular basis of CSCs, and provided numerous novel targets for anticancer therapy. However, the majority of recently identified targets remain &#8216;undruggable&#8217; through small-molecule agents, whereas the implications of exogenous RNA interference (RNAi, including siRNA and miRNA) may make it possible to translate our knowledge into therapeutics in a timely manner. With the recent advances of nanomedicine, in vivo delivery of RNAi using elaborate nanoparticles can potently overcome the intrinsic limitations of RNAi alone, as it is rapidly degraded and has unpredictable off-target side effects. Herein, we present an update on the development of RNAi-delivering nanoplatforms in CSC-targeted anticancer therapy and discuss their potential implications in clinical trials. Full article </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1008, tag: div, level: 13" node_number="1008"> (This article belongs to the Special Issue Novel Nanoparticles for Targeted Delivery of Therapeutic Nucleic Acids) </div> &#9658;&#9660; Show Figures <div class="valid" valid="valid" title="valid: True, node: 1009, tag: div, level: 13" node_number="1009"><div class="valid" valid="valid" title="valid: True, node: 1010, tag: div, level: 14" node_number="1010"><div title="valid: False, node: 1011, tag: div, level: 15" node_number="1011"><p title="valid: False, node: 1012, tag: p, level: 16" node_number="1012">Figure 1</p></div></div></div> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1013, tag: div, level: 9" node_number="1013"> More Articles... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 6" node_number="1014"> <div class="valid" valid="valid" title="valid: True, node: 1015, tag: div, level: 7" node_number="1015"> <div class="valid" valid="valid" title="valid: True, node: 1016, tag: div, level: 8" node_number="1016"> <div class="valid" valid="valid" title="valid: True, node: 1017, tag: div, level: 9" node_number="1017"> <a class="valid" valid="valid" title="valid: True, node: 1018, tag: a, level: 10" node_number="1018"> Submit to <i class="valid" valid="valid" title="valid: True, node: 1019, tag: i, level: 11" node_number="1019">Pharmaceutics</i> </a> Review for Pharmaceutics <div class="valid" valid="valid" title="valid: True, node: 1020, tag: div, level: 10" node_number="1020"> Share </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1021, tag: div, level: 9" node_number="1021"> <h2 class="valid" valid="valid" title="valid: True, node: 1022, tag: h2, level: 10" node_number="1022">Journal Menu</h2> &#9658; &#9660; Journal Menu <ul class="valid" valid="valid" title="valid: True, node: 1023, tag: ul, level: 10" node_number="1023"> <li class="valid" valid="valid" title="valid: True, node: 1024, tag: li, level: 11" node_number="1024"> <ul class="valid" valid="valid" title="valid: True, node: 1025, tag: ul, level: 12" node_number="1025"> <li class="valid" valid="valid" title="valid: True, node: 1026, tag: li, level: 13" node_number="1026"> Pharmaceutics Home </li> <li class="valid" valid="valid" title="valid: True, node: 1027, tag: li, level: 13" node_number="1027"> Aims Scope </li> <li class="valid" valid="valid" title="valid: True, node: 1028, tag: li, level: 13" node_number="1028"> Editorial Board </li> <li class="valid" valid="valid" title="valid: True, node: 1029, tag: li, level: 13" node_number="1029"> Reviewer Board </li> <li class="valid" valid="valid" title="valid: True, node: 1030, tag: li, level: 13" node_number="1030"> Topical Advisory Panel </li> <li class="valid" valid="valid" title="valid: True, node: 1031, tag: li, level: 13" node_number="1031"> Instructions for Authors </li> <li class="valid" valid="valid" title="valid: True, node: 1032, tag: li, level: 13" node_number="1032"> Special Issues </li> <li class="valid" valid="valid" title="valid: True, node: 1033, tag: li, level: 13" node_number="1033"> Sections Collections </li> <li class="valid" valid="valid" title="valid: True, node: 1034, tag: li, level: 13" node_number="1034"> Article Processing Charge </li> <li class="valid" valid="valid" title="valid: True, node: 1035, tag: li, level: 13" node_number="1035"> Indexing Archiving </li> <li class="valid" valid="valid" title="valid: True, node: 1036, tag: li, level: 13" node_number="1036"> Most Cited Viewed </li> <li class="valid" valid="valid" title="valid: True, node: 1037, tag: li, level: 13" node_number="1037"> Journal Statistics </li> <li class="valid" valid="valid" title="valid: True, node: 1038, tag: li, level: 13" node_number="1038"> Journal History </li> <li class="valid" valid="valid" title="valid: True, node: 1039, tag: li, level: 13" node_number="1039"> Journal Awards </li> <li class="valid" valid="valid" title="valid: True, node: 1040, tag: li, level: 13" node_number="1040"> Society Collaborations </li> <li class="valid" valid="valid" title="valid: True, node: 1041, tag: li, level: 13" node_number="1041"> Conferences </li> <li class="valid" valid="valid" title="valid: True, node: 1042, tag: li, level: 13" node_number="1042"> Editorial Office </li> </ul> </li> </ul> </div> <h2 class="valid" valid="valid" title="valid: True, node: 1043, tag: h2, level: 9" node_number="1043">Journal Browser</h2> &#9658; &#9660; Journal Browser <div class="valid" valid="valid" title="valid: True, node: 1044, tag: div, level: 9" node_number="1044"> <div class="valid" valid="valid" title="valid: True, node: 1045, tag: div, level: 10" node_number="1045"> <ul class="valid" valid="valid" title="valid: True, node: 1046, tag: ul, level: 11" node_number="1046"> <li class="valid" valid="valid" title="valid: True, node: 1047, tag: li, level: 12" node_number="1047"> <a class="valid" valid="valid" title="valid: True, node: 1048, tag: a, level: 13" node_number="1048"> <i class="valid" valid="valid" title="valid: True, node: 1049, tag: i, level: 14" node_number="1049"> arrow_forward_ios </i> Forthcoming issue </a> <a class="valid" valid="valid" title="valid: True, node: 1050, tag: a, level: 13" node_number="1050"> <i class="valid" valid="valid" title="valid: True, node: 1051, tag: i, level: 14" node_number="1051"> arrow_forward_ios </i> Current issue </a> </li> <div class="valid" valid="valid" title="valid: True, node: 1052, tag: div, level: 12" node_number="1052"> <div class="valid" valid="valid" title="valid: True, node: 1053, tag: div, level: 13" node_number="1053"> <div class="valid" valid="valid" title="valid: True, node: 1054, tag: div, level: 14" node_number="1054"> <li title="valid: False, node: 1055, tag: li, level: 15" node_number="1055"> Vol.&#160;13&#160;(2021) </li> <li title="valid: False, node: 1056, tag: li, level: 15" node_number="1056"> Vol.&#160;12&#160;(2020) </li> <li title="valid: False, node: 1057, tag: li, level: 15" node_number="1057"> Vol.&#160;11&#160;(2019) </li> <li title="valid: False, node: 1058, tag: li, level: 15" node_number="1058"> Vol.&#160;10&#160;(2018) </li> <li title="valid: False, node: 1059, tag: li, level: 15" node_number="1059"> Vol.&#160;9&#160;(2017) </li> <li title="valid: False, node: 1060, tag: li, level: 15" node_number="1060"> Vol.&#160;8&#160;(2016) </li> <li title="valid: False, node: 1061, tag: li, level: 15" node_number="1061"> Vol.&#160;7&#160;(2015) </li> <li title="valid: False, node: 1062, tag: li, level: 15" node_number="1062"> Vol.&#160;6&#160;(2014) </li> <li title="valid: False, node: 1063, tag: li, level: 15" node_number="1063"> Vol.&#160;5&#160;(2013) </li> <li title="valid: False, node: 1064, tag: li, level: 15" node_number="1064"> Vol.&#160;4&#160;(2012) </li> <li title="valid: False, node: 1065, tag: li, level: 15" node_number="1065"> Vol.&#160;3&#160;(2011) </li> <li title="valid: False, node: 1066, tag: li, level: 15" node_number="1066"> Vol.&#160;2&#160;(2010) </li> <li title="valid: False, node: 1067, tag: li, level: 15" node_number="1067"> Vol.&#160;1&#160;(2009) </li> </div> </div> </div> </ul> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 7" node_number="1068"> <div class="valid" valid="valid" title="valid: True, node: 1069, tag: div, level: 8" node_number="1069"> <h2 class="valid" valid="valid" title="valid: True, node: 1070, tag: h2, level: 9" node_number="1070">Highly Accessed Articles</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1071, tag: div, level: 8" node_number="1071"> <div class="valid" valid="valid" title="valid: True, node: 1072, tag: div, level: 9" node_number="1072"> View More... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1073, tag: div, level: 7" node_number="1073"> <div class="valid" valid="valid" title="valid: True, node: 1074, tag: div, level: 8" node_number="1074"> <h2 class="valid" valid="valid" title="valid: True, node: 1075, tag: h2, level: 9" node_number="1075">Latest Books</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1076, tag: div, level: 8" node_number="1076"> <div class="valid" valid="valid" title="valid: True, node: 1077, tag: div, level: 9" node_number="1077"> More Open Access Books... </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1078, tag: div, level: 6" node_number="1078"> <div class="valid" valid="valid" title="valid: True, node: 1079, tag: div, level: 7" node_number="1079"> <div class="valid" valid="valid" title="valid: True, node: 1080, tag: div, level: 8" node_number="1080"> <h2 class="valid" valid="valid" title="valid: True, node: 1081, tag: h2, level: 9" node_number="1081">E-Mail Alert</h2> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1082, tag: div, level: 7" node_number="1082"> <div class="valid" valid="valid" title="valid: True, node: 1083, tag: div, level: 8" node_number="1083"> <h2 class="valid" valid="valid" title="valid: True, node: 1084, tag: h2, level: 9" node_number="1084">News</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1085, tag: div, level: 8" node_number="1085"> <div class="valid" valid="valid" title="valid: True, node: 1086, tag: div, level: 9" node_number="1086"> 2 December 2021 Meet Us Virtually at the 1st International Electronic Conference on Processes: Processes System Innovation (ECP2022), 17&#8211;31 May 2022 </div> <div class="valid" valid="valid" title="valid: True, node: 1087, tag: div, level: 9" node_number="1087"> 22 November 2021 720 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction </div> <div class="valid" valid="valid" title="valid: True, node: 1088, tag: div, level: 9" node_number="1088"> 16 November 2021 Topical Advisory Panel Established to Support Editorial Board </div> <div class="valid" valid="valid" title="valid: True, node: 1089, tag: div, level: 9" node_number="1089"> More News Announcements... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1090, tag: div, level: 7" node_number="1090"> <div class="valid" valid="valid" title="valid: True, node: 1091, tag: div, level: 8" node_number="1091"> <h2 class="valid" valid="valid" title="valid: True, node: 1092, tag: h2, level: 9" node_number="1092">Topics</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1093, tag: div, level: 8" node_number="1093"> <div class="valid" valid="valid" title="valid: True, node: 1094, tag: div, level: 9" node_number="1094"><div class="valid" valid="valid" title="valid: True, node: 1095, tag: div, level: 10" node_number="1095"> Topic in Viruses, Biomedicines, Pharmaceuticals, Pharmaceutics, COVID</div> Broad-Spectrum Antiviral Agents Editors-in-Chief: Cheng-Wen Lin, Szu-Hao KungDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1096, tag: div, level: 9" node_number="1096"><div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 10" node_number="1097"> Topic in Antibiotics, Pharmaceutics, Pharmaceuticals, MPs</div> Emerging Material-Based Approaches to Chronic and Infectious Diseases Editor-in-Chief: Alan J. HibbittsDeadline: 31 May 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1098, tag: div, level: 9" node_number="1098"><div class="valid" valid="valid" title="valid: True, node: 1099, tag: div, level: 10" node_number="1099"> Topic in Biomedicines, Micromachines, Pharmaceutics, Nanomaterials, IJMS</div> Microfluidics Applied in Nanomedicine and Pharmaceutics Deadline: 31 December 2022</div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1100, tag: div, level: 7" node_number="1100"> <div class="valid" valid="valid" title="valid: True, node: 1101, tag: div, level: 8" node_number="1101"> <h2 class="valid" valid="valid" title="valid: True, node: 1102, tag: h2, level: 9" node_number="1102">Conferences</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1103, tag: div, level: 8" node_number="1103"> <div class="valid" valid="valid" title="valid: True, node: 1104, tag: div, level: 9" node_number="1104"> Announce Your Conference </div> <div class="valid" valid="valid" title="valid: True, node: 1105, tag: div, level: 9" node_number="1105"> 25&#8211;27 May 2022 Polymers 2022 -New Trends in Polymer Science: Health of the Planet, Health of the People</div> <div class="valid" valid="valid" title="valid: True, node: 1106, tag: div, level: 9" node_number="1106"> More Conferences... </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1107, tag: div, level: 7" node_number="1107"> <div class="valid" valid="valid" title="valid: True, node: 1108, tag: div, level: 8" node_number="1108"> <h2 class="valid" valid="valid" title="valid: True, node: 1109, tag: h2, level: 9" node_number="1109">Special Issues</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 8" node_number="1110"> <div class="valid" valid="valid" title="valid: True, node: 1111, tag: div, level: 9" node_number="1111"> Edit a Special Issue </div> <div class="valid" valid="valid" title="valid: True, node: 1112, tag: div, level: 9" node_number="1112"><div class="valid" valid="valid" title="valid: True, node: 1113, tag: div, level: 10" node_number="1113"> Special Issue in Pharmaceutics</div> Nanocarriers for Drug Delivery and/or Gene Therapy in Cancer Guest Editors: Bianca G&#462;l&#462;&#355;eanu, Marieta CostacheDeadline: 15 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1114, tag: div, level: 9" node_number="1114"><div class="valid" valid="valid" title="valid: True, node: 1115, tag: div, level: 10" node_number="1115"> Special Issue in Pharmaceutics</div> Advances in Liposome-Based Drug Delivery Systems Guest Editor: Zacharias SuntresDeadline: 31 December 2021</div> <div class="valid" valid="valid" title="valid: True, node: 1116, tag: div, level: 9" node_number="1116"><div class="valid" valid="valid" title="valid: True, node: 1117, tag: div, level: 10" node_number="1117"> Special Issue in Pharmaceutics</div> Liposomal Drug Delivery Systems Guest Editors: Antonio Mar&#237;a Rabasco &#193;lvarez, Mar&#237;a Luisa Gonz&#225;lez Rodr&#237;guezDeadline: 10 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 9" node_number="1118"><div class="valid" valid="valid" title="valid: True, node: 1119, tag: div, level: 10" node_number="1119"> Special Issue in Pharmaceutics</div> In Vivo Predictive Dissolution (iPD): Experimental and Mathematical Approaches and Regulatory Applications Guest Editors: Isabel Gonzalez-Alvarez, Peter LangguthDeadline: 20 January 2022</div> <div class="valid" valid="valid" title="valid: True, node: 1120, tag: div, level: 9" node_number="1120"> More Special Issues </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1121, tag: div, level: 7" node_number="1121"> <div class="valid" valid="valid" title="valid: True, node: 1122, tag: div, level: 8" node_number="1122"> <h2 class="valid" valid="valid" title="valid: True, node: 1123, tag: h2, level: 9" node_number="1123">Topical Collections</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1124, tag: div, level: 8" node_number="1124"> <div class="valid" valid="valid" title="valid: True, node: 1125, tag: div, level: 9" node_number="1125"><div class="valid" valid="valid" title="valid: True, node: 1126, tag: div, level: 10" node_number="1126"> Topical Collection in Pharmaceutics</div> Feature Papers in Pharmaceutical Technology Collection Editor: Thierry Vandamme</div> <div class="valid" valid="valid" title="valid: True, node: 1127, tag: div, level: 9" node_number="1127"><div class="valid" valid="valid" title="valid: True, node: 1128, tag: div, level: 10" node_number="1128"> Topical Collection in Pharmaceutics</div> Advanced Pharmaceutical Science and Technology in Korea Collection Editors: Hyo-Kyung Han, Beom-Jin Lee</div> <div class="valid" valid="valid" title="valid: True, node: 1129, tag: div, level: 9" node_number="1129"><div class="valid" valid="valid" title="valid: True, node: 1130, tag: div, level: 10" node_number="1130"> Topical Collection in Pharmaceutics</div> Advanced Pharmaceutical Science and Technology in Estonia Collection Editors: Karin Kogermann, Jana Lass</div> <div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 9" node_number="1131"><div class="valid" valid="valid" title="valid: True, node: 1132, tag: div, level: 10" node_number="1132"> Topical Collection in Pharmaceutics</div> 3D Printing and Bioprinting Applications in Pharmaceutics Collection Editors: Dimitrios A. Lamprou, Eneko Larra&#241;eta Landa</div> <div class="valid" valid="valid" title="valid: True, node: 1133, tag: div, level: 9" node_number="1133"> More Topical Collections </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1134, tag: div, level: 7" node_number="1134"> <div class="valid" valid="valid" title="valid: True, node: 1135, tag: div, level: 8" node_number="1135"> <h2 class="valid" valid="valid" title="valid: True, node: 1136, tag: h2, level: 9" node_number="1136">Jobs in Research</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1137, tag: div, level: 8" node_number="1137"> <div class="valid" valid="valid" title="valid: True, node: 1138, tag: div, level: 9" node_number="1138"> Post New Job Opening </div> </div> </div> </div> </div> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1139, tag: div, level: 3" node_number="1139"> <div class="valid" valid="valid" title="valid: True, node: 1140, tag: div, level: 4" node_number="1140"> Pharmaceutics, EISSN 1999-4923, Published by MDPI <span class="valid" valid="valid" title="valid: True, node: 1141, tag: span, level: 5" node_number="1141"> Disclaimer <div class="valid" valid="valid" title="valid: True, node: 1142, tag: div, level: 6" node_number="1142"> The statements, opinions and data contained in the journal Pharmaceutics are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> </span> <div class="valid" valid="valid" title="valid: True, node: 1143, tag: div, level: 5" node_number="1143"> RSS Content Alert </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1144, tag: div, level: 4" node_number="1144"> <div class="valid" valid="valid" title="valid: True, node: 1145, tag: div, level: 5" node_number="1145"> <h3 class="valid" valid="valid" title="valid: True, node: 1146, tag: h3, level: 6" node_number="1146"> Further Information </h3> <a class="valid" valid="valid" title="valid: True, node: 1147, tag: a, level: 6" node_number="1147"> Article Processing Charges </a> <a class="valid" valid="valid" title="valid: True, node: 1148, tag: a, level: 6" node_number="1148"> Pay an Invoice </a> <a class="valid" valid="valid" title="valid: True, node: 1149, tag: a, level: 6" node_number="1149"> Open Access Policy </a> <a class="valid" valid="valid" title="valid: True, node: 1150, tag: a, level: 6" node_number="1150"> Contact MDPI </a> <a class="valid" valid="valid" title="valid: True, node: 1151, tag: a, level: 6" node_number="1151"> Jobs at MDPI </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1152, tag: div, level: 5" node_number="1152"> <h3 class="valid" valid="valid" title="valid: True, node: 1153, tag: h3, level: 6" node_number="1153"> Guidelines </h3> <a class="valid" valid="valid" title="valid: True, node: 1154, tag: a, level: 6" node_number="1154"> For Authors </a> <a class="valid" valid="valid" title="valid: True, node: 1155, tag: a, level: 6" node_number="1155"> For Reviewers </a> <a class="valid" valid="valid" title="valid: True, node: 1156, tag: a, level: 6" node_number="1156"> For Editors </a> <a class="valid" valid="valid" title="valid: True, node: 1157, tag: a, level: 6" node_number="1157"> For Librarians </a> <a class="valid" valid="valid" title="valid: True, node: 1158, tag: a, level: 6" node_number="1158"> For Publishers </a> <a class="valid" valid="valid" title="valid: True, node: 1159, tag: a, level: 6" node_number="1159"> For Societies </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1160, tag: div, level: 5" node_number="1160"> <h3 class="valid" valid="valid" title="valid: True, node: 1161, tag: h3, level: 6" node_number="1161"> MDPI Initiatives </h3> <a class="valid" valid="valid" title="valid: True, node: 1162, tag: a, level: 6" node_number="1162"> Sciforum </a> <a class="valid" valid="valid" title="valid: True, node: 1163, tag: a, level: 6" node_number="1163"> MDPI Books </a> <a class="valid" valid="valid" title="valid: True, node: 1164, tag: a, level: 6" node_number="1164"> Preprints </a> <a class="valid" valid="valid" title="valid: True, node: 1165, tag: a, level: 6" node_number="1165"> Scilit </a> <a class="valid" valid="valid" title="valid: True, node: 1166, tag: a, level: 6" node_number="1166"> SciProfiles </a> <a class="valid" valid="valid" title="valid: True, node: 1167, tag: a, level: 6" node_number="1167"> Encyclopedia </a> <a class="valid" valid="valid" title="valid: True, node: 1168, tag: a, level: 6" node_number="1168"> JAMS </a> <a class="valid" valid="valid" title="valid: True, node: 1169, tag: a, level: 6" node_number="1169"> Proceedings Series </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1170, tag: div, level: 5" node_number="1170"> <h3 class="valid" valid="valid" title="valid: True, node: 1171, tag: h3, level: 6" node_number="1171"> Follow MDPI </h3> <a class="valid" valid="valid" title="valid: True, node: 1172, tag: a, level: 6" node_number="1172"> LinkedIn </a> <a class="valid" valid="valid" title="valid: True, node: 1173, tag: a, level: 6" node_number="1173"> Facebook </a> <a class="valid" valid="valid" title="valid: True, node: 1174, tag: a, level: 6" node_number="1174"> Twitter </a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1175, tag: div, level: 4" node_number="1175"> <div class="valid" valid="valid" title="valid: True, node: 1176, tag: div, level: 5" node_number="1176"> <div class="valid" valid="valid" title="valid: True, node: 1177, tag: div, level: 6" node_number="1177"> &#169; 1996-2021 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="valid" valid="valid" title="valid: True, node: 1178, tag: div, level: 6" node_number="1178"> <a class="valid" valid="valid" title="valid: True, node: 1179, tag: a, level: 7" node_number="1179"> Disclaimer </a> <div class="valid" valid="valid" title="valid: True, node: 1180, tag: div, level: 7" node_number="1180"> The statements, opinions and data contained in the journals are solely those of the individual authors and contributors and not of the publisher and the editor(s). MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. </div> <a class="valid" valid="valid" title="valid: True, node: 1181, tag: a, level: 7" node_number="1181"> Terms and Conditions </a> <a class="valid" valid="valid" title="valid: True, node: 1182, tag: a, level: 7" node_number="1182"> Privacy Policy </a> </div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1183, tag: div, level: 3" node_number="1183"> <div class="valid" valid="valid" title="valid: True, node: 1184, tag: div, level: 4" node_number="1184"> We use cookies on our website to ensure you get the best experience. Read more about our cookies <a class="valid" valid="valid" title="valid: True, node: 1185, tag: a, level: 5" node_number="1185">here</a>. </div> <div class="valid" valid="valid" title="valid: True, node: 1186, tag: div, level: 4" node_number="1186"> <a class="valid" valid="valid" title="valid: True, node: 1187, tag: a, level: 5" node_number="1187">Accept</a> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1188, tag: div, level: 3" node_number="1188"> <div class="valid" valid="valid" title="valid: True, node: 1189, tag: div, level: 4" node_number="1189"> We have just recently launched a new version of our website. Help us to further improve by taking part in this short 5 minute survey here. here. </div> <div class="valid" valid="valid" title="valid: True, node: 1190, tag: div, level: 4" node_number="1190"> <a class="valid" valid="valid" title="valid: True, node: 1191, tag: a, level: 5" node_number="1191">Never show this again</a> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 1192, tag: div, level: 2" node_number="1192"> <div class="valid" valid="valid" title="valid: True, node: 1193, tag: div, level: 3" node_number="1193"> <div class="valid" valid="valid" title="valid: True, node: 1194, tag: div, level: 4" node_number="1194"> <h2 class="valid" valid="valid" title="valid: True, node: 1195, tag: h2, level: 5" node_number="1195">Share Link</h2> </div> <div class="valid" valid="valid" title="valid: True, node: 1196, tag: div, level: 4" node_number="1196"> <a class="valid" valid="valid" title="valid: True, node: 1197, tag: a, level: 5" node_number="1197">Copy</a> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1198, tag: a, level: 3" node_number="1198"> <i class="valid" valid="valid" title="valid: True, node: 1199, tag: i, level: 4" node_number="1199">clear</i> </a> </div> <div class="valid" valid="valid" title="valid: True, node: 1200, tag: div, level: 2" node_number="1200"> <div class="valid" valid="valid" title="valid: True, node: 1201, tag: div, level: 3" node_number="1201"> <div class="valid" valid="valid" title="valid: True, node: 1202, tag: div, level: 4" node_number="1202"> <h2 class="valid" valid="valid" title="valid: True, node: 1203, tag: h2, level: 5" node_number="1203">Share</h2> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 1204, tag: a, level: 3" node_number="1204"> <i class="valid" valid="valid" title="valid: True, node: 1205, tag: i, level: 4" node_number="1205">clear</i> </a> </div> <a class="valid" valid="valid" title="valid: True, node: 1206, tag: a, level: 2" node_number="1206">Back to TopTop</a> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>